InvestorBrandNetwork (IBN) Content Platform

May 15, 2025 15:25:00

The marijuana sector is facing a growing financial crisis that’s been developing quietly while many businesses ignore the signs. The core issue? An explosion in unpaid invoices that’s threatening to destabilize the entire supply chain. Despite some whispers in online forums and informal industry circles, there has been little serious discussion about the scale of the problem or the risks it poses.

It would be interesting to hear how vertically-integrated medical marijuana entities like Trulieve Cannabis Corp. (Cboe CA: TRUL) (OTCQX: TCNNF) are managing to…

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

TechMediaBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare

May 15, 2025 14:49:00

Adageis, a forward-thinking healthcare technology company, is empowering clinics and medical groups to succeed in the shift from fee-for-service to value-based care through its AI-powered platform. The company’s ProActive Care solution deciphers complex insurance contracts, integrates with leading EHR systems, and offers real-time analytics to help providers track revenue trends as well as their performance and profitability. Proprietary components of the platform, including the Value-Based Care Engine and Patented Risk Engine, identify care gaps and high-risk patients, enabling earlier interventions that enhance both clinical and financial performance. By developing targeted solutions, with a focus on smaller and independent practices, Adageis aims to make value-based care more accessible and profitable while driving data-driven operational decisions.

To view the full article, visit https://ibn.fm/245SM

About Adageis

Adageis is a healthcare technology innovator focused on addressing inefficiencies in care delivery through AI and machine learning. Its solutions empower healthcare providers and healthcare organizations to enhance patient outcomes, streamline operations, and drive increased revenue through meeting the demands of value-based care. By integrating advanced technologies with minimal disruption, Adageis remains a leader in driving meaningful change across the healthcare sector. For more information, visit the company’s website at www.Adageis.com.

NOTE TO INVESTORS: The latest news and updates relating to Adageis are available in the company’s newsroom at https://ibn.fm/Adageis

About TechMediaWire

TechMediaWire (“TMW”) is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances

May 15, 2025 14:04:05

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, is expanding its market presence and manufacturing capabilities through two new strategic partnerships. The company is collaborating with Charlotte FC to build brand visibility, particularly for its AI Tape and AVERSA(TM)—Nutriband’s proprietary technology that it believes has the potential to be the world’s first and only abuse deterrent patch platform for managing chronic pain. The company also deepened its collaboration with Kindeva Drug Delivery through an amended agreement focused on the development of Aversa(TM) Fentanyl, which combines Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. Through existing and new alliances with established brands in the health and wellness industry, Nutriband aims to diversify its revenue streams and reinforce its position as a leader in transdermal drug delivery solutions.

To view the full article, visit https://ibn.fm/2YofM

About Nutriband Inc.

Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is an abuse deterrent fentanyl patch incorporating its AVERSA(TM) abuse-deterrent technology. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. For more information about the company, visit www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial

May 15, 2025 11:56:42

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted this week in a Zacks Small-Cap Research report that presented a favorable analysis, noting that the company’s Phase 3 cutaneous T-cell lymphoma (“CTCL”) study is continuing and that the trial has a high probability of success.

According to the report, Soligenix is conducting a Phase 3 FLASH2 trial of HyBryte(TM) in patients with CTCL. The Zacks report noted that the FLASH2 trial is similar in design to the recently completed successful Phase 3 FLASH trial. The one key difference between the trials is that in the FLASH trial patients were treated for three cycles of six weeks each, with a two-week break in between cycles. The primary efficacy endpoint for the FLASH trial was measured after the first treatment cycle.

“In the FLASH2 trial, patients will be treated for 18 consecutive weeks before the primary efficacy endpoint is assessed,” the report noted. “Based on the results from the FLASH trial, we believe the FLASH2 trial has a high probability of success, and we anticipate topline results in 2026.”

To view the full report, visit https://ibn.fm/I58Bp

About Soligenix Inc. 

Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte(TM) (“SGX301” or synthetic hypericin) as a novel photodynamic therapy utilizing safe visible light for the treatment of cutaneous T-cell lymphoma (“CTCL”). With successful completion of the second Phase 3 study, regulatory approvals will be sought to support potential commercialization worldwide. Development programs in this business segment also include expansion of synthetic hypericin (“SGX302”) into psoriasis, the company’s first-in-class innate defense regulator (“IDR”) technology, dusquetide (“SGX942”) for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer, and (“SGX945”) in Behçet’s disease. 

The company’s Public Health Solutions business segment includes development programs for RiVax(R), its ricin toxin vaccine candidate, as well as its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax(TM), the company’s vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of Soligenix’s vaccine programs incorporates the use of its proprietary heat stabilization platform technology, known as ThermoVax(R). To date, this business segment has been supported with government grants and contract funding from the National Institute of Allergy and Infectious Diseases (“NIAID”), the Defense Threat Reduction Agency (“DTRA”) and the Biomedical Advanced Research and Development Authority (“BARDA”). 

For further information, visit the company’s website at www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Secures $7.8M to Launch Clinic Rollup Strategy

May 15, 2025 11:35:00

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a term sheet with Universal Capital, LLC for $7.8 million in acquisition funding to support the rollout of its national interventional psychiatry clinic network. Combined with previously announced investments, HOPE now has $10.3 million in capital to execute initial acquisitions of Dura Medical, Kadima, and NeuroSpa. These clinics offer neuroplastic treatments such as ketamine and transcranial magnetic stimulation to treat severe depression and PTSD, with current contracts in place to serve veterans through the VA. Universal Capital expects to participate in future funding rounds as HOPE expands its platform nationwide.

To view the full press release, visit https://ibn.fm/CTks1

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

For more information, please visit https://www.nrxpharma.com/

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

D-Wave Quantum Inc. (NYSE: QBTS) Reports Record First Quarter Revenue, Gross Profit and Cash Position

May 15, 2025 10:20:00

The company posted record quarterly revenue of $15 million, up over 500% from Q1 2024.
Gross profit surged to $13.9 million, driven by a high-margin Advantage™ quantum system sale.
The company ended Q1 with $304.3 million in cash, its highest quarter-end balance in the company’s history.
Customer count grew to 133, with 69 commercial users including 25 Forbes Global 2000 firms.

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, reported a significant increase in revenue, gross profit, and cash reserves for the first quarter of fiscal 2025, enabled by the sale of a high-margin annealing quantum computing system. The results, detailed in a conference call hosted by CEO Dr. Alan Baratz and CFO John Markovich on May 8, signal the company’s continuing momentum in driving commercial adoption of quantum computing (https://ibn.fm/UoZWf).

Quarterly revenue came in at $15 million, a 509% increase from the same period last year, when the company reported $2.5 million. The growth was primarily attributed to a system sale recognized in the quarter, underscoring an additional revenue stream for the company beyond its traditional…

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our 5,000+ qubit Advantage quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our Advantage and Advantage2 systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

Massimo Group (NASDAQ: MAMO) Rides the Wave of Growing Powersports

May 15, 2025 09:35:00

The global powersports market is projected to grow to $60.51 billion by 2032.
Recreational boating market size is expected to observe around a 10% CAGR from 2024 to 2032.
Massimo Group has strategically positioned itself to leverage these market trends.

The powersports and recreational watercraft industries are experiencing a notable upswing, driven by consumers’ growing appetite for outdoor adventures and leisure activities. Amid this surge, Massimo (NASDAQ: MAMO), a Texas-based manufacturer and distributor, is emerging as a significant player, capitalizing on market trends and expanding its footprint in the sector.

The global powersports market, encompassing vehicles like ATVs, UTVs and bikes, was valued at $37.96 billion in 2023 and is projected to grow to $60.51 billion by 2032, reflecting a compound annual growth rate (“CAGR”) of 5.4% (https://ibn.fm/b205e). This growth is fueled by increasing consumer interest in…

NOTE TO INVESTORS: The latest news and updates relating to MAMO are available in the company’s newsroom at https://ibn.fm/MAMO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally

May 15, 2025 09:30:13

Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in 24 countries and partners with 18 distributors across 19 nations. These milestones support the company’s global expansion strategy and position it for entry into the multi-billion-dollar U.S. testing market.

To view the full article, visit https://ibn.fm/XoMP5

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/INBS

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO) Unveils Breakthrough Silver(II) Antimicrobial Drug Candidate Telomir-Ag2

May 15, 2025 09:10:37

Telomir Pharmaceuticals (NASDAQ: TELO) announced the identification of Telomir-Ag2, a stabilized Silver(II) complex demonstrating potent, broad-spectrum antimicrobial activity, including against drug-resistant MARSA. Developed using the company’s proprietary Telomir-1 platform, Telomir-Ag2 is the first Silver(II) compound to achieve biological compatibility, outperforming its Silver(I) predecessor in preclinical studies. Designed for use in high-risk infections such as burns and surgical wounds, the drug candidate targets the growing $1.36 billion silver wound care market and $33.7 billion antimicrobial coatings market. Telomir plans to advance Telomir-Ag2 into IND-enabling studies and explore strategic partnerships.

To view the full press release, visit https://ibn.fm/D8SkK

About Telomir Pharmaceuticals

Telomir Pharmaceuticals is a preclinical stage pharmaceutical company seeking to lead development in longevity science in both humans and animals. The company is focused on the development of Telomir-1, a novel small molecule designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomeres are the protective end caps of a chromosome made up of DNA sequences and proteins. As humans age, telomeres shorten, with metal reactivity accelerating the process, which presents humans and pet animals with an increased chance of contracting a number of degenerative and age-related diseases. Telomir’s goal is to develop, gain regulatory approval for and commercialize Telomir-1, proposed to be dosed orally, with the broader aim of promoting longevity and enhancing overall quality of life. For more information about the company, visit the website www.Telodx.com.

NOTE TO INVESTORS: The latest news and updates relating to TELO are available in the company’s newsroom at https://ibn.fm/TELO

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

Will Trump’s Executive Order on Drug Prices Yield the Desired Results

May 15, 2025 09:05:00

While President Trump signed an order aimed at reducing the high cost of prescription drugs in the U.S., it isn’t clear how exactly the price reduction will be achieved and how such reductions could impact the country in the long term.

It would be interesting to hear what Medical Advantage plan providers like Astiva Health think about the practicality of the…

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Reaffirms $50M 2026 Revenue Target Ahead of CSI Acquisition Close

May 15, 2025 09:05:00

Datavault AI (NASDAQ: DVLT) filed Q1 2025 results and reaffirmed its 2026 revenue target of $40 million to $50 million, projecting $12 million to $15 million in revenue in the second half of 2025. The company expects to close its acquisition of CompuSystems Inc. during the week of May 19. Recent strategic milestones include joining IBM’s Partner Plus, licensing its ADIO(R) ultrasonic advertising tech to NYIAX, and launching a secure tokenized data vending platform with Kove IO. Datavault also advanced its VerifyU strategy through a deal with the NFL Alumni Association.

To view the full press release, visit https://ibn.fm/omjlh

About Datavault AI Inc.

Datavault AI (Nasdaq: DVLT) is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R)(IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.datavaultsite.com.

NOTE TO INVESTORS: The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

AI is Bound to Replace Some Employees, But Not Just Yet

May 15, 2025 09:05:00

The growing interest in artificial intelligence (AI) is raising concerns about misinformation and premature decision-making. A notable example involved a fabricated quote attributed to Apple CEO Tim Cook. When asked to provide statements from tech leaders on the relevance of AI in modern business, OpenAI’s ChatGPT generated a quote that claimed AI was boosting efficiency and growth. However, upon further inquiry, the chatbot revealed that no such comment had been officially made by Cook in any verified speech or communication.

The better approach seems to be to leverage AI to improve the productivity of employees in ways that enterprises like Thumzup Media Corp. (NASDAQ: TZUP) are providing AI-enhanced solutions that…

About AINewsWire

AINewsWire (“AINW”) is a specialized communications platform with a focus on the latest advancements in artificial intelligence (“AI”), including the technologies, trends and trailblazers driving innovation forward. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, AINW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, AINW brings its clients unparalleled recognition and brand awareness.

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

Geopolitical Risks, Dropping Prices are Shaping the Energy Storage Market

May 15, 2025 09:05:00

The energy storage sector is undergoing a transformative shift, with lithium iron phosphate (LFP) batteries taking center stage. Experts speaking ahead of the upcoming NetZero Milan Expo-Summit 2025 emphasize that LFP’s growing dominance has been driven by advantages such as enhanced safety, longer lifespan, reduced costs, and consistent performance.

For companies like Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) looking to…

About MiningNewsWire

MiningNewsWire (“MNW”) is a specialized communications platform with a focus on developments and opportunities in the Global Mining and Resources sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled recognition and brand awareness.

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Battery Swapping Offers Avenue to Accelerate EV Adoption

May 15, 2025 09:05:00

Battery swapping is becoming a popular alternative to conventional charging in several markets. As the name suggests, this process involves exchanging a depleted EV battery with a fully charged one, eliminating the long wait times associated with traditional electric vehicle charging. As an alternative to plug-in charging, battery swapping offers a user experience that can be just as fast as refueling a gasoline-powered car.

As many battery makers like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) seek to create business relationships with…

About GreenCarStocks

GreenCarStocks (“GCS”) is a specialized communications platform with a focus on electric vehicles (“EVs”) and the green energy sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled recognition and brand awareness. GCS is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Advances Redtail Virotherapy Platform and Reduces Q1 Losses

May 15, 2025 09:01:13

Calidi Biotherapeutics (NYSE American: CLDI) reported a Q1 2025 net loss of $5.0 million, narrowing from $7.2 million in the prior year, with R&D and G&A expenses also declining. The company highlighted FDA clearance of its IND for CLD-201, an allogeneic stem cell-based immunotherapy for solid tumors, and presented promising Redtail platform data at AACR showcasing IL15 superagonist delivery via engineered oncolytic virus. Calidi also announced key leadership additions, including CEO Dr. Eric Poma and CMO Dr. Guy Clifton, as it advances systemic virotherapies targeting metastatic cancers.

To view the full press release, visit: https://ibn.fm/mqF2M

About Calidi Biotherapeutics

Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s novel stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California.

For more information, please visit www.calidibio.com

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Applauds Imminent Eagle Football IPO, Sees Boost for Multi-Club Investment Visibility

May 15, 2025 08:55:00

Brera Holdings (NASDAQ: BREA) welcomed reports that Eagle Football Holdings, a $2 billion multi-club ownership group, is preparing to file for an IPO. Eagle’s portfolio includes stakes in Crystal Palace, Lyon, Botafogo, and Molenbeek. Brera Executive Chairman Dan McClory expressed support for the move, citing its potential to raise investor awareness of the MCO model and sports as an asset class. Brera, which completed its own Nasdaq listing in 2023, said it continues aligning with the sustainable football investment approach recently highlighted in The Wall Street Journal.

To view the full press release, visit https://ibn.fm/2g33t

About Brera Holdings PLC

Brera Holdings PLC is focused on expanding its social impact football (soccer) business by developing a global portfolio of emerging football and other sports clubs, which will provide increased opportunities to earn tournament prizes, gain sponsorships, provide other professional football and sports-related consulting services, and achieve capital appreciation of these clubs.

For more information, visit the company’s website at www.BreraHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at http://ibn.fm/BREA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Vivakor Inc. (NASDAQ: VIVK) Is ‘One to Watch’

May 15, 2025 08:50:00

Vivakor achieved substantial revenue growth in 2023, driven by expanded logistics operations and newly integrated midstream assets.
The company operates a large-scale oilfield trucking fleet under long-term contracts, providing recurring revenue and service continuity.
Its remediation facilities, once operational, will address a produced water treatment market forecast to reach $12.2 billion by 2028.
Recent acquisitions have enhanced Vivakor’s infrastructure footprint and extended its service reach across key U.S. energy basins.
The company’s integrated model aligns with industry trends favoring sustainability, compliance, and full-cycle fluid management.

Vivakor (NASDAQ: VIVK) is a vertically integrated energy infrastructure and environmental services company, focused on the transportation, storage, reuse, and remediation of oilfield fluids and waste. The company operates a large-scale oilfield trucking fleet, serving key U.S. energy regions, enabling end-to-end solutions for the handling of crude oil and produced water. Through long-term contracts and strategic asset positioning, Vivakor delivers critical services to upstream energy operators seeking efficient and environmentally responsible operations.

Vivakor’s vision is to become a leader in sustainable energy logistics and remediation by combining innovative infrastructure with environmentally conscious practices. The company’s integrated model allows it to optimize the flow and treatment of petroleum-based materials across the…

NOTE TO INVESTORS: The latest news and updates relating to VIVK are available in the company’s newsroom at https://ibn.fm/VIVK

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Taps Thermo Fisher for Phase 3 and Commercial Production of CYB003

May 15, 2025 08:45:00

Cybin (NYSE American: CYBN) (NEO: CYBN) has partnered with Thermo Fisher Scientific to support Phase 3 clinical supply and potential commercial manufacturing of CYB003, its proprietary deuterated psilocin treatment for major depressive disorder (MDD). The agreement expands on Cybin’s existing U.S.-based manufacturing operations, with Thermo Fisher handling drug substance in South Carolina and capsule production in Ohio. CYB003 received FDA Breakthrough Therapy Designation in March 2024, and its ongoing Phase 3 PARADIGM™ trial follows strong Phase 2 results showing a 100% response rate and 71% remission with two 16 mg doses.

To view the full press release, visit https://ibn.fm/Q29gC

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Reports Record Q1 Revenue and Expands Plug & Play Footprint

May 15, 2025 08:35:00

SKYX Platforms (NASDAQ: SKYX) reported record Q1 2025 revenue of $20.1 million, up 6% year-over-year, driven by growth in its smart and standard plug & play product sales. The company’s gross profit rose to $5.7 million while net loss per share narrowed to ($0.09). SKYX raised $4 million in new equity as part of a $15 million financing round led by The Shaner Group and company insiders. Strategic collaborations with Home Depot, Wayfair, Cavco Homes, and multiple luxury developments are expanding market penetration. Management reaffirmed expectations for positive cash flow in 2025 as its products reach 30,000 homes by the end of Q2 and continue scaling across the U.S. and Canada.

To view the full press release, visit https://ibn.fm/B5ZCe

About SKYX Platforms Corp.

As electricity is a standard in every home and building, our mission is to make homes and buildings become safe-advanced and smart as the new standard. SKYX has a series of highly disruptive advanced-safe-smart platform technologies, with over 97 U.S. and global patents and patent pending applications. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. We believe that our products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, please visit our website at https://skyplug.com/ or follow us on LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to SKYX are available in the company’s newsroom at https://ibn.fm/SKYX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

RockBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Launches New Investor Awareness Campaigns Across North America and Europe

May 15, 2025 08:35:00

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) has initiated a series of investor awareness and marketing agreements aimed at expanding its visibility. The Company engaged InvestorBrandNetwork for a yearlong communications campaign starting May 8, 2025, at $23,200 per quarter, and Goldinvest Consulting for six months beginning May 5 to support outreach in Germany at EUR 4,050 per month. Ucore also signed a 12-month media agreement with Outside the Box Capital, which includes $160,000 in cash, 100,000 stock options, and a $25,000 influencer campaign budget, pending TSXV approval.

To view the full press release, visit https://ibn.fm/5lZS1

About Ucore Rare Metals Inc.

Ucore is focused on rare- and critical-metal resources, extraction, beneficiation, and separation technologies with the potential for production, growth, and scalability. Ucore’s vision and plan is to become a leading advanced technology company, providing best-in-class metal separation products and services to the mining and mineral extraction industry.

Through strategic partnerships, this plan includes disrupting the People’s Republic of China’s control of the North American REE supply chain through the near-term establishment of a heavy and light rare-earth processing facility in the U.S. State of Louisiana, subsequent Strategic Metal Complexes in Canada and Alaska and the longer-term development of Ucore’s 100% controlled Bokan-Dotson Ridge Rare Heavy REE Project on Prince of Wales Island in Southeast Alaska, USA.

Ucore is listed on the TSXV under the trading symbol “UCU” and in the United States on the OTC Markets’ OTCQX(R) Best Market under the ticker symbol “UURAF.”

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/UURAF

About Rocks & Stocks

Rocks & Stocks (“R&S”) is a specialized communications platform delivering deep insights into the mining industry. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, R&S is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, R&S brings its clients unparalleled recognition and brand awareness.

R&S is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Rocks & Stocks, text “Rocks” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://RocksAndStocks.news

Please see full terms of use and disclaimers on the Rocks & Stocks website applicable to all content provided by R&S, wherever published or re-published: https://RocksAndStocks.news/Disclaimer

Rocks & Stocks
Austin, Texas
RocksAndStocks.news
512.354.7000 Office
[email protected]

Rocks & Stocks is powered by IBN

TinyGemsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Reports 246% Revenue Growth and Expanding Tour Adoption in Q1

May 15, 2025 08:30:00

Newton Golf Company (NASDAQ: NWTG) reported a 246% year-over-year revenue increase to $1.2 million in Q1 2025, driven by surging demand for its Newton Motion and Fast Motion shafts. Gross profit rose to $852,000 with margin expansion to 70%, while net loss narrowed to $0.5 million. More than 30 professionals have adopted Newton shafts, including 8 new players across major tours in Q1. The company also expanded into Japan, added key international distribution, and expects full-year revenue between $6.5 million and $7.0 million.

To view the full press release, visit https://ibn.fm/cMPw9

About Newton Golf

At Newton Golf, we harness the power of physics to revolutionize golf equipment design. Formerly known as Sacks Parente, our rebranding reflects our commitment to innovation inspired by Sir Isaac Newton, the father of physics. By applying Newtonian principles to every aspect of our design process, we create precision-engineered golf clubs that deliver unmatched stability, control, and performance. Our mission is to empower golfers with scientifically advanced equipment that maximizes consistency and accuracy, ensuring every swing is backed by the laws of physics.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
[email protected]

TinyGems is powered by IBN

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Engages Veloxity Labs for IND-Enabling Study of PTSD Drug SPC-15

May 15, 2025 08:25:00

Silo Pharma (NASDAQ: SILO) has partnered with Veloxity Labs to conduct GLP-compliant bioanalysis for its ongoing toxicology and toxicokinetics study of SPC-15, an intranasal treatment aimed at preventing PTSD. The data will support an FDA investigational new drug submission expected in 2025. If approved, Silo plans to advance SPC-15 into a Phase 1 human clinical trial.

To view the full press release, visit https://ibn.fm/Bo8ag

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug-delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder (“PTSD”) and stress-induced anxiety disorders. SP-26 is a time-release, ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with universities and independent laboratories. For more information about the company, visit www.SiloPharma.com .

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) Delivers Free Cash Flow and $24.4M Q1 Profit, Advances Oko West

May 15, 2025 08:15:00

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) reported Q1 2025 gold production of 35,578 ounces at an all-in sustaining cost of $960/oz, generating $24.4 million in net income and $36.0 million in free cash flow. With $149 million in cash and no lost time or recordable incidents, the company remains on track to meet 2025 guidance. GMIN advanced early works at Oko West and released a feasibility study outlining a $2.2 billion NPV at $2,500 gold. Proven and probable reserves rose to 6.7 million ounces, and the company gained inclusion in three major mining indices, boosting institutional visibility.

To view the full press release, visit https://ibn.fm/kZXfk

About G Mining Ventures Corp.

G Mining Ventures Corp. is a mining company engaged in the acquisition, exploration and development of precious metal projects to capitalize on the value uplift from successful mine development. GMIN is well-positioned to grow into the next mid-tier precious metals producer by leveraging strong access to capital and proven development expertise. GMIN is currently anchored by the Tocantinzinho Gold Mine (” TZ “) in Brazil and Oko West Project in Guyana , both mining friendly and prospective jurisdictions.

NOTE TO INVESTORS: The latest news and updates relating to GMINF are available in the company’s newsroom at https://ibn.fm/GMINF

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Report Q1 2025 Results and Host Investor Webinar Today

May 15, 2025 08:15:00

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will release its financial results for the quarter ended March 31, 2025, after market close today, May 15, and will host a webinar at 4:30 p.m. ET to provide a business update and discuss the quarterly performance.

To view the full press release, visit https://ibn.fm/27iAY

About SolarBank Corporation

SolarBank Corporation is an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the USA. The Company develops solar, Battery Energy Storage System (BESS) and EV Charging projects that sell electricity to utilities, commercial, industrial, municipal and residential off-takers. The Company maximizes returns via a diverse portfolio of projects across multiple leading North America markets including projects with utilities, host off-takers, community solar, and virtual net metering projects. The Company has a potential development pipeline of over one gigawatt and has developed renewable and clean energy projects with a combined capacity of over 100 megawatts built. For more information, visit the company’s website at SolarBankCorp.com. This report contains forward looking information. Please refer to https://ibn.fm/nX2Ns for additional details.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

Sustain Southern California Presents: Agriculture, Food Systems & Waste Stream Innovations

May 15, 2025 08:05:00

Sustain Southern California is proud to announce this year’s Agriculture, Food Systems & Waste Stream Innovations event, promising an agenda packed with solutions in circularity. Scheduled for May 15 from 1:00 p.m. to 7:00 p.m., this event brings together key stakeholders in agriculture to discuss agtech, urban agriculture, composting needs, policy issues, and more.

Attendees are guaranteed to learn about farm-to-table initiatives while also having an opportunity to discover how society can shift waste-sorting behaviors. In addition, they will learn what opportunities lie in secondary markets, showing how to stay ahead of the curve and adjust operations for maximum…

To learn more, please visit https://ibn.fm/jn7RE.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q1 Revenue of $14.5M, Expands Airtime Business Despite Healthcare Headwinds

May 15, 2025 08:05:00

NextPlat (NASDAQ: NXPL, NXPLW) reported Q1 2025 revenue of $14.5 million, down from $17.5 million in the prior year, driven by changes in 340B pharmacy agreements and prescription volume. Gross margin declined to 23.8%, while operating expenses fell 26% to $4.9 million due to reduced legal and non-recurring costs. Net loss narrowed to $1.3 million, or ($0.05) per share. The company ended the quarter with $17.7 million in cash and expanded its e-Commerce reach, including a 51% increase in recurring airtime revenue and growing OPKO product sales in China. Management remains focused on high-margin services and strategic healthcare growth.

To view the full press release, visit: https://ibn.fm/6s3JS

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc.

NOTE TO INVESTORS: The latest news and updates relating to NXPL are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

US House Points Guns on Clean Energy, Climate Policies in Budget Proposals

May 15, 2025 08:05:00

The Trump administration is considering eliminating various Biden-era climate action policies designed to invest in America’s burgeoning green energy industry. U.S. House representatives recently introduced plans to phase out renewable energy tax credits, cut federal spending on clean energy and electric vehicles, and pull back funding dedicated to climate action in an attempt to pass a budget that aligns with President Donald Trump’s anti-green energy agenda.

It remains to be seen how these policy changes will impact the trajectory of companies like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) that had positioned themselves to address the market for clean energy solutions like solar systems in the U.S. and other major…

About GreenEnergyStocks

GreenEnergyStocks (“GES”) is a specialized communications platform with a focus on companies working to shape the future of the green economy. GreenEnergyStocks is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, GES is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, GES brings its clients unparalleled recognition and brand awareness. GES is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

China Races Ahead in Revolutionizing Battery Technology

May 15, 2025 08:05:00

In the global race to develop better, faster, and more efficient batteries, China is quickly emerging as a clear leader. While many countries are still exploring new possibilities, China has already taken major steps in transforming battery technology, with real-world results to show for it.

The battery race is well underway, and at the moment, China is far ahead. Will American companies like QuantumScape Corp. (NYSE: QS) help the U.S. to catch up? Only time can tell…

About BillionDollarClub

BillionDollarClub (“BDC”) is a specialized communications platform with a focus on the biggest and brightest companies covered by IBN. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BDC is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, BDC brings its clients unparalleled recognition and brand awareness.

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

Please see full terms of use and disclaimers on the BillionDollarClub website applicable to all content provided by BDC, wherever published or re-published: https://www.BillionDollarClub.com/Disclaimer

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

Trump to Host Top Buyers of His Meme Coin to Exclusive Dinner

May 15, 2025 08:05:00

U.S. President Donald Trump’s latest venture into the crypto world is stirring up controversy, criticism, and speculation. On Monday, the top two hundred and twenty investors in a Trump-branded digital token secured an invitation to a private dinner with the president. The dinner, scheduled for May 22 in Washington, D.C., is being presented as a reward for those who spent the most on the crypto known as $TRUMP.

What do major crypto industry actors like HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) think about Trump’s heavy involvement in crypto projects? Their opinions are likely to be mixed since benefits can come from his involvement but it could also be a minefield if the tide…

About CryptoCurrencyWire

CryptoCurrencyWire (“CCW”) is a specialized communications platform with a focus on blockchain and the cryptocurrency sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled recognition and brand awareness. CCW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire website applicable to all content provided by CCW, wherever published or re-published: https://www.CryptoCurrencyWire.com/Disclaimer

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

420 with CNW — Governor Hochul Signs Budget, Lawmakers Exclude Marijuana Smell as Authorization for Police Searches

May 14, 2025 15:25:00

New York Governor Kathy Hochul signed the state’s latest budget into law on Friday, but one key proposal that had stirred significant backlash didn’t make it into the final version. Earlier this year, Hochul had proposed allowing police to use the smell of cannabis as a reason to suspect a driver of being under the influence and require them to undergo a drug test.

The entire marijuana industry around the country, including major firms like Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF), will be relieved that the…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MiningNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Positioned to Accelerate Storm Copper Project in Nunavut

May 14, 2025 14:42:32

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), through its joint venture with American West Metals, has secured a strategic partnership with Ocean Partners Holdings to significantly advance the Storm Copper Project in Nunavut, Canada. The deal includes up to 80% project development financing and a binding offtake agreement granting Ocean Partners exclusive rights to copper and silver products from near-surface mineralization. Backed by a US$3.5 million second tranche payment from Taurus Mining Royalty and C$0.996 million to Aston Bay, the funding will support aggressive exploration and pre-feasibility efforts in 2025.

A recent article quotes Thomas Ullrich, CEO of Aston Bay, as saying, “We are thrilled to announce this strategic partnership and funding package for the Storm Copper Project. Ocean Partners is an experienced global leader in ore-sorting and direct shipping ore (‘DSO’) copper project development; they bring both funding and the technical know-how to advance the project. The partnership speaks to the quality of the project and the American West/Aston Bay joint venture team, validation of the project, and highlights a low-risk pathway to potential development.”

To view the full article, visit https://ibn.fm/L6Yy1

About Aston Bay Holdings Ltd.

Aston Bay is a publicly traded mineral exploration company exploring for high-grade copper and gold deposits in Virginia, USA, and Nunavut, Canada. The company is currently exploring the Storm Project property and Cu-Ag-Zn-Co Epworth property in Nunavut, as well as the high-grade Buckingham Gold Vein and critical metals prospects in central Virginia. The company is also in advanced stages of negotiation on other lands with high-grade copper potential in North America. The company and its joint venture partners, American West Metals Limited and its wholly owned subsidiary, Tornado Metals Ltd. (collectively, “American West”), formed a 20/80 unincorporated joint venture in respect of the Storm Project property, which hosts the Storm Copper Project and the Seal Zinc Deposit. Under the unincorporated joint venture, Aston Bay shall have a free carried interest until American West has made a decision to mine upon completion of a bankable feasibility study, meaning American West will be solely responsible for funding the joint venture until such decision is made. After such decision is made, Aston Bay will be diluted in the event it does not elect to contribute its proportionate share and its interest in the Storm Project property will be converted into a 2% net smelter returns royalty if its interest is diluted to below 10%. Further details are available on the company’s website at https://astonbayholdings.com.

NOTE TO INVESTORS: The latest news and updates relating to ATBHF are available in the company’s newsroom at https://ibn.fm/ATBHF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Austin, Texas
www.MiningNewsWire.com
512.354.7000 Office
[email protected]

MiningNewsWire is powered by IBN

PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Set to Report Q1 Earnings in Wake of HOPE’s Strategic Kadima Agreement

May 14, 2025 14:25:19

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) is scheduled to report its first quarter 2025 financial results after the market closes on Thursday, May 15. A conference call and webcast will follow at 4:30 p.m. ET, accessible via the company’s investor relations site or by dialing +1-800-717-1738 (U.S.) or +1-646-307-1865 (international).

The earnings update comes shortly after news that NRx’s wholly owned subsidiary, HOPE Therapeutics, signed a definitive agreement to acquire Kadima Neuropsychiatry Institute in La Jolla, California. Kadima is a profitable clinic and leader in psychedelic and neuroplastic research, offering treatments for suicidal depression, PTSD and other CNS conditions. It is expected to serve as the model for HOPE’s national clinic rollout.

To view the full press release announcing the Kadima agreement, visit https://ibn.fm/sxSUl

About NRx Pharmaceuticals Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (preservative-free IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the U.S. National Institutes of Health and newly obtained data from French health authorities, licensed under a data-sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the U.S. FDA as part of a protocol to treat patients with acute suicidality and has filed a patent for this novel formulation with the U.S. Patent and Trademark Office.

For further information, visit the company’s website at www.NRxPharma.com

About PsychedelicNewsWire

PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

PsychedelicNewsWire
Austin, Texas
www.PsychedelicNewsWire.com
512.354.7000 Office
[email protected]

PsychedelicNewsWire is powered by IBN

CannabisNewsBreaks – Whoopi Goldberg to Take the Stage at CMB 2025

May 14, 2025 14:07:34

Cannabis Means Business (“CMB”) today announced that Whoopi Goldberg will participate in a fireside chat and launch her new hemp-derived beverage, Whoop-Tea, at CMB 2025, taking place on June 4–5 at the Javits Center in New York City. The Emmy, Grammy, Oscar, and Tony Award-winning entertainer and entrepreneur will join CNBC’s Tim Seymour on Wednesday, June 4, for an exclusive conversation in the Special Events Area on the CMB exhibit floor. The discussion will delve into the fast-rising cannabis beverage market and the vision behind Whoop-Tea, created in collaboration with leading cannabis beverage brand Pure Genesis.

“I wanted to create something that’s fun, relaxing, and brings people together—without the hangover,” said Whoopi Goldberg. “Whoop-Tea is exactly that. It’s tea, it’s lemonade, it’s THC, and it’s all about unwinding and enjoying the moment. I’m excited to bring this to CMB and to be part of this incredible shift in wellness culture.”

To view the full press release, visit https://cnw.fm/Trex7

About Cannabis Means Business (“CMB”)

CMB, formerly CWCBExpo, is the premier North American trade show and conference for professionals and companies who are serious about growth, innovation and building their business in cannabis. As champions of a responsible, ethical, sustainable and profitable cannabis ecosystem, CMB reflects the vibrancy and complexity of New York City—a global hub for business, innovation and the cannabis supply chain. For more information, visit www.CannabisMeansBusiness.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Austin, Texas
www.CannabisNewsWire.com
512.354.7000 Office
[email protected]

CannabisNewsWire is powered by IBN

InvestorNewsBreaks – From Farm to Future: Sustainability in Focus at Sustain SoCal’s May Event

May 14, 2025 11:20:00

Sustain Southern California (“Sustain SoCal”) has announced its upcoming event, Agriculture, Food Systems and Waste Stream Innovations, slated to take place in Irvine, California, on Thursday, May 15, 2025. The synergistic agenda will drive comprehensive discussions along the entire spectrum of the supply chain, from agtech, farm-to-table, packaging innovations, and waste management policy.

“We are pleased to offer a new initiative… which shall provide a new-age forum for industry experts, businesspersons and agricultural enterprises, policymakers and academics,” said C. Scott Kitcher, president and CEO of Sustain SoCal. “To drive progress on sustainability, it is more important than ever to take a multi-pronged strategy integrating our knowledge of farmers’ challenges, restaurant business practices, technology-enabled sustainability practices, end-of-life strategies, wider educational initiatives and public innovations, and sharpen the design, adoption and implementation of supportive regulatory regimes and outreach activities. At the May event, invited experts will also share their perspectives and practical opportunities on agricultural science, business, behavioral and policy innovation, and sustainable circularity in the farm-to-restaurant supply chain and other secondary waste markets.”

To view the full press release, visit https://ibn.fm/2m1jg

About Sustain SoCal

Sustain SoCal, a non-profit organization, accelerates sustainability and economic growth through innovation, collaboration and education in Southern California. The organization has a ten-year history of exploring and implementing pragmatic, real-world solutions to the challenges created by growth, change and inefficiency. It conducts conferences, workshops and networking events that lead to initiatives that positively impact the region’s economic progress and sustainability. For more information, please visit www.SustainSoCal.org.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks – SurgePays, Inc. (Nasdaq: SURG) Secures $7M Convertible Note to Fuel LinkUp Mobile Launch and Wholesale Expansion

May 14, 2025 10:52:28

SurgePays (Nasdaq: SURG) has entered into a $7 million senior secured convertible note agreement with a current institutional shareholder, providing $6 million in cash and involving a repurchase of 333,333 shares. The two-year note is convertible into common stock at $4.00 per share, a premium to current market price, and includes a prepayment option at a 2% premium. Proceeds will support the national launch of LinkUp Mobile and the growth of SurgePays’ MVNE wholesale platform following its April 1 integration with AT&T. Management projects over $200 million in revenue and positive cash flow from operations by year-end 2025.

To view the full press release, visit https://ibn.fm/Fae3M

About SurgePays, Inc.

SurgePays, Inc. is a wireless and fintech company focused on delivering mobile connectivity and financial services to underserved communities. As both a mobile virtual network operator (“MVNO”) and mobile virtual network enabler (MVNE), SurgePays operates its own wireless brand while also providing back-end infrastructure, including provisioning and billing, to other wireless providers. The Company’s proprietary point-of-sale platform is used nationwide in thousands of retail locations, enabling SIM activations, top-ups, and digital financial services. SurgePays is built to scale and uniquely positioned to grow across both retail and wholesale wireless channels.

For more information, visit the company’s website at: https://surgepays.com/

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral as Measles and MPox Resurge Globally

May 14, 2025 09:55:15

NanoViricides, Inc. (NYSE American: NNVC) provided a strategic update on its antiviral pipeline, highlighting NV-387 as a potential breakthrough treatment for Measles and MPox amid rising global case counts and vaccine failures. The company has begun preparations for animal efficacy studies for Measles and will make NV-387 available under FDA’s Individual Patient Expanded Access. In the DRC, its Phase II Clinical Trial Application for MPox has been cleared by the national ethics committee. NV-387 is also being developed for broad respiratory infections in a basket trial format and for pan-herpesvirus treatment. With no current approved drugs for Measles or MPox, NanoViricides aims to fill critical gaps in global antiviral preparedness.

To view the full press release, visit https://ibn.fm/6gtcL

About NanoViricides Inc.

NanoViricides is a development-stage company that is creating special purpose nanomaterials for antiviral therapy. The company’s novel nanoviricide(TM) class of drug candidates and the nanoviricide(TM) technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments. The company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005. NanoViricides’ lead drug candidate is NV-387, a broad-spectrum antiviral drug that the company plans to develop as a treatment of RSV, COVID-19, Long COVID, influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. The company is currently focused on advancing NV-387 into Phase II human clinical trials. NanoViricides’ other advanced candidate is NV-HHV-1 for the treatment of Shingles. The company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. NV-CoV-2 (“API NV-387”) is the company’s nanoviricide drug candidate for COVID-19 that does not encapsulate remdesivir. NV-CoV-2-R is NanoViricides’ other drug candidate for COVID-19 that is made up of NV-387 with remdesivir encapsulated within its polymeric micelles. For more information about the company, visit www.NanoViricides.com.

NOTE TO INVESTORS: The latest news and updates relating to NNVC are available in the company’s newsroom at https://ibn.fm/NNVC

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

Simple Hand Motion Test Could Reveal Undetected Brain Tumor

May 14, 2025 09:05:00

A viral video on social media platform TikTok is popularizing a quick and easy hand test that can reportedly reveal if someone has an undiagnosed brain tumor. The British medic who demonstrated the 30-second test on the TikTok account claims that it can help individuals identify serious brain health issues that haven’t been diagnosed yet.

With companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) heavily investing in…

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office

Toyota Warns That Falling Behind the Chinese Goes Beyond EVs

May 14, 2025 09:05:00

When most people think about electric cars, China isn’t the first name that comes to mind, but maybe it should be. Toyota has just sounded the alarm, and it’s not just about electric vehicles anymore. According to the company, China’s rise in the auto world is happening fast and across more than one area.

For EV companies like Mullen Automotive Inc. (NASDAQ: MULN) that are looking to…

NOTE TO INVESTORS: The latest news and updates relating to Mullen Automotive Inc. (NASDAQ: MULN) are available in the company’s newsroom at https://ibn.fm/MULN

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with FDA-Requested Safety Study for SPC-15

May 14, 2025 09:05:00

Silo Pharma (NASDAQ: SILO) has partnered with Frontage Laboratories to conduct a 7-day safety and toxicology study of its lead asset, SPC-15, following a request from the FDA. The intranasal treatment targets PTSD and stress-related disorders, and the study is expected to strengthen Silo’s upcoming IND application. Silo remains on track for an FDA submission this year and is concurrently running a GLP-compliant toxicology study. SPC-15, developed in collaboration with Columbia University, is a 5-HT4 receptor agonist potentially eligible for the FDA’s 505(b)(2) pathway.

To view the full press release, visit https://ibn.fm/ABqjm

About Silo Pharma Inc.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Grows Q1 Revenue 29% and Narrows Losses Ahead of Investor Showcase

May 14, 2025 08:55:00

Knightscope (NASDAQ: KSCP) reported Q1 2025 revenue of $2.9 million, up 29% year-over-year, while net loss narrowed to $6.9 million, a 19% improvement. The company improved gross margin loss to (23%) from (64%) and cut G&A expenses by 24%. Knightscope ended the quarter with $12.7 million in cash and a $2.5 million backlog. Strategic initiatives included securing a 33,000-square-foot headquarters in Sunnyvale, California, and raising $8.8 million in equity offerings. The company will present at the Ladenburg Thalmann Innovation EXPO25 on May 21 in New York.

To view the full press release, visit https://ibn.fm/vt4qv

About Knightscope, Inc.

Knightscope builds cutting-edge technologies to improve public safety. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Massimo Group (NASDAQ: MAMO): Digital Pivot Targets Nationwide Revenue Growth

May 14, 2025 08:50:00

New online platform enables national reach with end-to-end purchasing and financing
Management anticipates higher sales volume and deeper market penetration in 2025
Powersports industry demand remains strong, supported by outdoor recreation and rural mobility trends

Massimo (NASDAQ: MAMO) is entering a new growth phase with the launch of a comprehensive digital retail platform. This move, announced in April 2025, is designed to simplify the purchasing process for its UTVs, ATVs, and mini-bikes, while expanding the company’s national sales footprint.

The platform enables customers to complete transactions online, including financing, titling, and checkout, providing a fully digital experience. Massimo expects this shift to unlock greater…

NOTE TO INVESTORS: The latest news and updates relating to MAMO are available in the company’s newsroom at https://ibn.fm/MAMO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Joseph Hand as General Counsel and EVP of Operations

May 14, 2025 08:45:00

Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings decades of leadership experience across legal, HR, and corporate services, including a pivotal role in Celgene’s $74 billion acquisition by Bristol Myers Squibb and the $13.4 billion divestiture of Otezla® to Amgen. His addition comes as Tonix prepares for a potential launch of TNX-102 SL for fibromyalgia, pending FDA approval.

To view the full press release, visit https://ibn.fm/7BKOa

About Tonix Pharmaceuticals Holding Corp.

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and modernizing solutions for public health challenges. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) this month for TNX-102 SL, a product candidate for which two statistically significant phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL was generally well tolerated in the phase 3 program. The FDA has granted Fast Track designation to TNX-102 SL for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix recently announced that the U.S. Department of Defense (“DoD”), Defense Threat Reduction Agency (“DTRA”) awarded it a contract for up to $34 million over five years to develop TNX-4200, small molecule broad-spectrum antiviral agents targeting CD45 for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Tonix owns and operates a state-of-the art infectious disease research facility in Frederick, Maryland. The company’s Good Manufacturing Practice (“GMP”)-capable advanced manufacturing facility in Dartmouth, Maryland, was purpose-built to manufacture TNX-801, and the GMP suites are ready to be reactivated in case of a national or international emergency. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic in Phase 2 development designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R)(sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to TNXP are available in the company’s newsroom at https://ibn.fm/TNXP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Highlights Near-Term Production Strategy on MiningNewsWire Podcast

May 14, 2025 08:45:00

ESGold (CSE: ESAU) (OTCQB: ESAUF) President Brad Kitchen appeared on the latest episode of The MiningNewsWire Podcast to discuss the company’s fully permitted Montauban project and near-term path to gold and silver production. Kitchen emphasized ESGold’s unique model of funding exploration through early-stage tailings production, citing an estimated $100 million in recoverable material from the historic mine. He also highlighted the project’s community impact, operational goals for 2025, and a tightly aligned marketing plan to increase visibility as production ramps.

To view the full press release, visit https://ibn.fm/1qrus

About ESGold Corp.

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is a fully permitted, pre-production resource company at the forefront of clean mining and exploration innovation. With proven expertise in Quebec, the Company is advancing its projects toward production and feasibility while delivering long-term value through sustainable resource recovery and exploration. ESGold’s flagship Montauban property, located 80 kilometers west of Quebec City, serves as a model for responsible mining practices, combining near-term production with district-scale discovery potential.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Austin, Texas
www.MiningNewsWire.com
512.354.7000 Office
[email protected]

MiningNewsWire is powered by IBN

BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Hits FDA Milestone and Expands Strategic Partnerships in Q1 Update

May 14, 2025 08:35:00

HeartBeam (NASDAQ: BEAT) reported Q1 2025 results highlighted by successful completion of the VALID-ECG pivotal study, supporting its 510(k) submission for 12-lead ECG synthesis software and confirming productive ongoing FDA discussions. The company launched an Early Access Program, signed a strategic partnership with AccurKardia to integrate its FDA-cleared AccurECG(TM) software, added two new U.S. patents to bring its IP total to 20, appointed CEO Robert Eno to its board, and raised $11.5 million through a public offering to support commercialization plans.

To view the full press release, visit https://ibn.fm/Gnz4f

About HeartBeam Inc.

HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care — all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. For more information, visit www.HeartBeam.com .

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

TechMediaBreaks – FAVO Capital Inc. (FAVO) to Present Growth Strategy at D. Boral Capital Inaugural Global Conference

May 14, 2025 08:35:00

FAVO Capital (OTC: FAVO), a provider of revenue-based funding solutions for SMBs, announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. President Shaun Quin will represent the company in meetings with institutional investors, highlighting FAVO’s growth strategy and IPO readiness. CEO Vincent Napolitano emphasized the event as a key platform to expand visibility and engage potential investors ahead of the company’s planned uplisting.

To view the full press release, visit https://ibn.fm/TNW4T

About FAVO Capital Inc.

FAVO Capital is a fast-growing alternative finance company specializing in flexible, technology-driven funding solutions for emerging, small and medium-sized businesses. Headquartered in Fort Lauderdale, Florida, FAVO leverages advanced underwriting models and a client-centric approach to bridge gaps left by traditional lenders. With a commitment to efficiency, flexibility and long-term growth, FAVO Capital is dedicated to providing scalable financial solutions that help businesses access the capital they need to succeed in an evolving market. For more information, visit www.FAVOCapital.com.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Alliance Global Partners Healthcare Showcase on May 21

May 14, 2025 08:30:00

Cybin (NYSE American: CYBN) (NEO: CYBN) announced that CEO Doug Drysdale will participate in a fireside chat at the virtual Alliance Global Partners Healthcare Company Showcase on May 21, 2025. The session will be webcast live at 1:40 p.m. ET and later available via the company’s investor relations site.

To view the full press release, visit https://ibn.fm/mwOhv

About Cybin Inc.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.PsychedelicNewsWire.com

PsychedelicNewsWire
Austin, Texas
www.PsychedelicNewsWire.com
512.354.7000 Office
[email protected]

PsychedelicNewsWire is powered by IBN

BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor

May 14, 2025 08:30:00

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on brain and central nervous system cancers, has priced a “reasonable best efforts” public offering with a single healthcare-focused institutional investor, raising approximately $5 million in gross proceeds. The offering includes 3,952,570 shares of common stock at $1.265 per share and accompanying Series F warrants to purchase an equal number of shares at $1.14 per share, exercisable immediately and valid for five years. A.G.P./Alliance Global Partners is acting as the sole placement agent. Proceeds will be used for working capital and general corporate purposes. Closing is expected on or about May 14, 2025.

To view the full press release, visit https://ibn.fm/olurM

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Advances Phase 3 Alzheimer’s Trial and Expands Conference Presence in Q1

May 14, 2025 08:26:19

Annovis Bio (NYSE: ANVS) initiated its pivotal Phase 3 clinical trial in early Alzheimer’s disease during Q1 2025, with enrollment now underway for up to 760 participants to assess buntanetap’s symptomatic and disease-modifying effects over 18 months. The company also secured a new U.S. patent for buntanetap and participated in several key scientific and investor conferences, including Oppenheimer’s 35th Annual Healthcare Life Sciences Conference and AD/PD(TM) 2025 in Vienna. Cash and equivalents rose to $22.2 million as of March 31, 2025, while R&D expenses fell year-over-year to $5.0 million.

To view the full press release, visit https://ibn.fm/nmp36

About Annovis Bio Inc.

Annovis Bio, headquartered in Malvern, Pennsylvania, is committed to addressing neurodegeneration in diseases such as Alzheimer’s and Parkinson’s. The company is developing innovative therapies that target multiple neurotoxic proteins, with the goal of restoring brain function and improving the quality of life for patients.

For more information, visit the company’s website at www.AnnovisBio.com, and social channels LinkedIn, X and YouTube.

NOTE TO INVESTORS: The latest news and updates relating to ANVS are available in the company’s newsroom at https://ibn.fm/ANVS

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Appoints Kris Pederson to Board, Adds Scientific Advisor to Advance Tech and Governance

May 14, 2025 08:25:00

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson, a veteran corporate director with leadership roles at EY, IBM (NYSE: IBM), and PwC, to its Board of Directors effective May 1, 2025, where she will also chair the Nominating and Corporate Governance Committee. The Company also named Dr. Benjamin Sanchez as a Scientific Advisor in February to support federal funding and clinical research partnerships. The additions bring deep expertise in governance, digital innovation, and biomedical engineering as SOBRsafe continues scaling its alcohol detection technology platform.

To view the full press release, visit https://ibn.fm/A5xP1

About SOBRsafe(TM)

Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way. Enter SOBRsafe(TM), where advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin – no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next-generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration. The SOBRsafe technology is commercially available for point-of-care screening (“SOBRcheck”) and continuous monitoring (“SOBRsure”). SOBRsafe is creating a culture of prevention and support. To learn more, visit www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

MiningNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Expands North American REE Refining Plans as RapidSX(TM) Nears Commissioning

May 14, 2025 08:15:00

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF) is nearing the commissioning of its RapidSX(TM) Commercial Demonstration Plant in Kingston, Ontario, a key milestone in its plan to commercialize its advanced rare earth element (REE) separation technology. The company is also preparing to construct its first Strategic Metals Complex (SMC) in Louisiana, expected to process 2,000 tons of total rare earth oxides by the end of 2024 and scale to 5,000 tons in 2026. Ucore’s long-term roadmap includes additional SMCs in Alaska and Canada, alongside the development of its 100%-owned Bokan-Dotson Ridge HREE resource in Alaska. With strong U.S. and Canadian government support and partnerships with Kingston Process Metallurgy and Mech-Chem Associates, Ucore aims to establish a complete North American REE supply chain independent of China.

To view the full press release, visit https://ibn.fm/5kLDa

About Ucore Rare Metals Inc.

Ucore is listed on the TSXV under the trading symbol “UCU” and in the United States on the OTC Markets’ OTCQX(R) Best Market under the ticker symbol “UURAF.”

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/UURAF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Austin, Texas
www.MiningNewsWire.com
512.354.7000 Office
[email protected]

MiningNewsWire is powered by IBN

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Secures $4 Million Strategic Investment as Part of $15 Million Funding Round

May 14, 2025 08:05:00

SKYX Platforms (NASDAQ: SKYX), a smart home platform technology company with over 97 issued and pending patents, announced it has raised approximately $4 million from strategic investors through preferred stock priced at $2.00 per share. The investment is part of a broader $15 million financing round led by The Shaner Group, with additional participation from SKYX insiders including President Steve Schmidt and Co-CEOs Lenny Sokolow and John Campi. The funding will support general working capital and corporate initiatives as the company advances its home innovation platform and e-commerce portfolio.

To view the full press release, visit https://ibn.fm/4T7gi

About SKYX Platforms Corp.

NOTE TO INVESTORS: The latest news and updates relating to SKYX are available in the company’s newsroom at https://ibn.fm/SKYX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Nickel Miners in Indonesia Decry Royalty Rate Increase, Warn of Possible Layoffs

May 14, 2025 08:05:00

The nickel mining industry in Indonesia has reacted negatively to the government’s increase of mining royalties from 10% to rates that vary from 14-19%. The change took effect at the start of May. The government is looking at these increased royalties as a source of needed revenue to fund the ambitious programs initiated by President Subianto. For example, he started a program to offer free meals for pregnant mothers and children. He has also established a sovereign wealth fund for the country.

For companies like Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) with planned mining operations expected to yield nickel as a by-product of gold production, the developments in Indonesia could be of interest since they may have an impact on the global market for various…

About Rocks & Stocks

R&S is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Rocks & Stocks, text “Rocks” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://RocksAndStocks.news

Please see full terms of use and disclaimers on the Rocks & Stocks website applicable to all content provided by R&S, wherever published or re-published: https://RocksAndStocks.news/Disclaimer

Rocks & Stocks
Los Angeles, CA
RocksAndStocks.news
310.299.1717 Office
[email protected]

Rocks & Stocks is powered by IBN

ONAR Holding Corp. (ONAR) Leads the Charge in AI-Driven Marketing with Proprietary Platform

May 14, 2025 08:05:00

The AI marketing market is projected to surge to more than $107.5 billion by 2028
ONAR Holding recently announced the launch of ONAR Labs, its dedicated technology incubator
The company also unveiled its first product offering: Cortex, an AI-powered marketing intelligence platform

Artificial intelligence (“AI”) is rapidly transforming the marketing landscape, enabling businesses to deliver more personalized, efficient and data-driven campaigns. As companies seek to harness the power of AI to stay competitive, ONAR Holding Corp. (OTCQB: ONAR) is at the forefront with its innovative Cortex platform, poised to redefine the future of advertising.

The adoption of AI in marketing has seen exponential growth in recent years. According to a report by All About AI, the AI marketing market, valued at $15.84 billion in 2021, is projected to surge to more than $107.5 billion by 2028 (https://ibn.fm/lf5bb). This growth is driven by the increasing demand for data…

NOTE TO INVESTORS: The latest news and updates relating to ONAR are available in the company’s newsroom at https://ibn.fm/ONAR

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

420 with CNW — Trump Announces Withdrawal of Controversial Prohibitionist Nominee for Washington Attorney

May 13, 2025 15:25:00

President Donald Trump has announced that he’s pulling his nomination for Ed Martin, who was set to become the U.S. attorney for Washington, D.C.

The broader marijuana industry, including firms like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), will be relieved that a nominee that…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

InvestorNewsBreaks – MoneyShow’s Virtual Expo to Deliver Strategic Insights on Maximizing Potential in Volatile Times

May 13, 2025 12:35:00

MoneyShow, a leading producer of live and online financial conferences for investors, traders, and financial advisors, today announced the upcoming “Navigating Volatility, Finding Opportunity: A Virtual Expo,” set to take place May 21-22, 2025. “Investors face several key issues in this market environment. They include far-reaching U.S. tariffs, geopolitical tensions, inflation concerns, evolving trade dynamics, the potential for interest rate cuts, and the surge in safe-haven assets,” said MoneyShow’s Editor-in-Chief Mike Larson. “Our star-studded line-up of speakers will provide attendees with in-depth context to the latest market moves. They will also share highly actionable insights on minimizing risks in choppy seas, maximizing profit avenues, and repositioning portfolios to manage uncertainty across the second half of the year.”

To view the full press release, visit https://ibn.fm/yigJm

About MoneyShow

MoneyShow has a long history of creating successful investors and traders through timely investing and trading education, delivered by powerful experts who are best-selling authors, market analysts, portfolio managers, award-winning financial journalists, and newsletter editors. With MoneyShow’s interactive environment, its audience of over one million passionate investors and traders are offered a unique format of live, interactive exchange, which generates unparalleled experience for both the expert and the investor and trader. With constant network expansion, MoneyShow continues to create broader distribution of its expert commentary through virtual events, face-to-face forums, social media, and in-depth courses that educate and guide qualified investors and traders to outperform the market. Each session energizes, empowers and educates everyone who participates. The opportunity for learning and profit within this highly charged atmosphere draws hundreds of thousands of enthusiasts, year after year.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

GreenCarNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reaches Settlement Agreement with GEM Over Mishawaka Assets

May 13, 2025 09:19:20

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced it has executed a settlement agreement with GEM Yield Bahamas Limited and GEM Global Yield LLC SCS, resolving a four-year legal dispute. Under the agreement, GEM has a 55-day due diligence period—subject to extension—to evaluate the transfer of Mullen’s Mishawaka assets in full satisfaction of the judgment. All collection activities will be suspended during this period. Mullen stated it remains focused on expanding its Tunica, Mississippi, manufacturing operations to meet growing demand across its EV product lines.

To view the full press release, visit https://ibn.fm/sOuN2

About Mullen Automotive Inc.

Mullen Automotive is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”) with two United States-based vehicle plants located in Tunica, Mississippi, (120,000 square feet) and Mishawaka, Indiana (650,000 square feet). In August 2023, Mullen began commercial vehicle production in Tunica. In September 2023, Mullen received IRS approval for federal EV tax credits on its commercial vehicles with a Qualified Manufacturer designation that offers eligible customers up to $7,500 per vehicle. As of January 2024, both the Mullen ONE, a Class 1 EV cargo van, and Mullen THREE, a Class 3 EV cab chassis truck, are California Air Resource Board (“CARB”) and EPA certified and available for sale in the U.S. The CARB-issued HVIP approval on the Mullen THREE, Class 3 EV truck, provides up to a $45,000 cash voucher at time of vehicle purchase. The company has also recently expanded its commercial dealer network to seven dealers with the addition of Papé Kenworth. Other previously announced dealers include Pritchard EV, National Auto Fleet Group, Ziegler Truck Group, Range Truck Group, Eco Auto, and Randy Marion Auto Group, providing sales and service coverage in key Midwest, West Coast, Pacific Northwest, New England and Mid-Atlantic markets. The company has also announced Foreign Trade Zone (“FTZ”) status approval for its Tunica, Mississippi, commercial vehicle manufacturing center. FTZ approval provides a number of benefits, including deferment of duties owed and elimination of duties on exported vehicles. For more information about the company, visit www.MullenUSA.com.

NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Austin, Texas
www.GreenCarStocks.com
512.354.7000 Office
[email protected]

GreenCarStocks is powered by IBN

TechMediaBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0) Expands Into Africa with Focus on Cybersecurity for Government and Enterprise Clients

May 13, 2025 09:11:58

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a Swiss-hosted cybersecurity and private communications platform, has initiated discussions with multiple referral partners to launch its privacy-focused solutions across several African countries. The move targets enterprise and government clients, especially in high-risk sectors such as education, telecom, and public administration, in response to the continent’s growing exposure to cyber threats. Sekur’s communications suite, which includes encrypted email, messaging, and VPN services, will soon feature multi-tiered authorization for added enterprise security. All services are hosted in Switzerland under strict federal data protection laws, supporting Sekur’s commitment to global privacy standards.

To view the full press release, visit https://ibn.fm/EznnJ

About Sekur Private Data Ltd.

Sekur Private Data is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The company distributes a suite of encrypted emails, secure messengers and secure communication tools. It sells its products through its own website, approved distributors and telecommunication companies worldwide. Sekur Private Data serves consumers, businesses and governments worldwide. For more information, visit the company’s website at www.Sekur.com.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://ibn.fm/SWISF

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

Zalando Looks to AI to Cut Costs, Speed Up Marketing Efforts

May 13, 2025 09:05:00

European fashion e-commerce giant Zalando is using generative AI to create images for its website and app more quickly, reflecting how artificial intelligence is changing the fashion industry and helping businesses cut costs.

The changes being made by Zalando illustrate how transformative the AI solutions being commercialized by various actors like D-Wave Quantum Inc. (NYSE: QBTS) can be in the…

NOTE TO INVESTORS: The latest news and updates relating to D-Wave Quantum Inc. (NYSE: QBTS) are available in the company’s newsroom at https://ibn.fm/QBTS

About AINewsWire

AINW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from AINewsWire, text “AI” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit www.AINewsWire.com

Please see full terms of use and disclaimers on the AINewsWire website applicable to all content provided by AINW, wherever published or re-published: https://www.AINewsWire.com/Disclaimer

AINewsWire
Los Angeles, CA
www.AINewsWire.com
310.299.1717 Office
[email protected]

AINewsWire is powered by IBN

Study Links Higher Consumption of Ultra-Processed Foods to Heightened Psoriasis Risk

May 13, 2025 09:05:00

A recently conducted study has found a strong link between the intake of ultra-processed foods (UPFs) and a higher risk of developing psoriasis. The findings of this research appeared in the Nutrients journal.

Given that UPF consumption is accelerating rapidly around the world, there is an urgent need to raise awareness about the risks of these foods, and also develop effective treatments against this condition. Entities like Soligenix Inc. (NASDAQ: SNGX) are looking to address the…

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

Baker Hughes Says Oil, Gas Rigs in the US Have Reduced Significantly

May 13, 2025 09:05:00

A recent report by energy technology company Baker Hughes reveals that U.S. energy firms have slashed the number of active oil and natural gas rigs to their lowest levels since the beginning of the year. According to the report, the number of oil rigs fell to 474, while natural gas rigs remained unchanged.

Any easing of the current macroeconomic uncertainties could put the industry back on firm footing and give enterprises like GEMXX Corp. (OTC: GEMZ) a path to offering…

NOTE TO INVESTORS: The latest news and updates relating to GEMXX Corp. (OTC: GEMZ) are available in the company’s newsroom at https://ibn.fm/GEMZ

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

Foxtron Announces Project to Develop, Make EVs for Mitsubishi

May 13, 2025 09:05:00

The largest contract electronics manufacturer in the world has teamed up with Mitsubishi to develop and manufacture electric cars for the Japanese automaker. Foxconn, also referred to as Hon Hai Technology Group, has been seeking opportunities to enter the burgeoning electric vehicle sector for quite some time. The world-leading electronics manufacturer now appears to have completed its years-long quest to enter electric vehicle development.

Existing entities like Mullen Automotive Inc. (NASDAQ: MULN) need to…

NOTE TO INVESTORS: The latest news and updates relating to Mullen Automotive Inc. (NASDAQ: MULN) are available in the company’s newsroom at https://ibn.fm/MULN

About GreenCarStocks

To receive SMS alerts from GreenCarStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the GreenCarStocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

GreenCarStocks
Los Angeles, CA
www.GreenCarStocks.com
310.299.1717 Office
[email protected]

GreenCarStocks is powered by IBN

InvestorNewsBreaks – FAVO Capital Inc. (FAVO) Converts Super Voting Shares to Support Nasdaq Uplisting Plans

May 13, 2025 08:55:00

FAVO Capital (OTC: FAVO), a private credit firm focused on merchant cash advances and revenue-based financing for underserved SMBs, announced the voluntary conversion of all outstanding Super Voting Series C Preferred Shares into common stock. The move simplifies the company’s capital structure, eliminates super voting rights, and aligns with public market governance standards as FAVO continues its preparations for a planned uplisting to the Nasdaq Capital Market. CEO Vincent Napolitano said the decision reflects FAVO’s commitment to transparency, best practices, and long-term value creation for shareholders.

To view the full press release, visit https://ibn.fm/P2tP6

About FAVO Capital Inc.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/FAVO

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks – ONAR Holding Corporation (OTCQB: ONAR) Engages IBN to Lead Corporate Communications Strategy

May 13, 2025 08:53:54

ONAR (OTCQB: ONAR), a global marketing technology firm specializing in AI-driven solutions for revenue acceleration, has selected IBN to lead its corporate communications initiatives. ONAR, which operates across performance, healthcare, and experiential marketing, aims to redefine middle-market marketing through innovation and strategic acquisitions. The company is rapidly growing its global footprint and integrating specialized agencies under one brand to deliver superior client outcomes. Through this partnership, IBN will deploy its expansive distribution network—including 5,000+ syndication outlets and millions of followers across 70+ brands—to amplify ONAR’s visibility among investors and the broader market.

To view the full article, visit https://ibn.fm/eKy38

About ONAR

ONAR (OTCQB: ONAR) is a leading marketing technology company and marketing agency network, now publicly traded as Onar Holding Corporation. ONAR’s mission is to provide unparalleled marketing services that drive revenue growth through an integrated, AI-driven approach. Committed to honor, candor, and best-in-class results, ONAR aims to lead the industry by example, ensuring every client relationship is deeply rooted in trust and excellence.

ONAR has nearly 50 employees across five continents, and it is aggressively expanding its team to support the company’s growth and acquisition pipeline. Its agencies service over 45 clients across various industries:

Performance Marketing & SEO: Our high-touch performance marketing agency, Storia, specializes in brand growth, data-driven excellence, and paid advertising.

Full-Service Healthcare Marketing: Partnering with healthcare professionals, Of Kos provides the best possible patient experience and strives to revolutionize the standard of care.

Experiential Marketing & Events: CHALK is an experiential marketing powerhouse of event architects who turn bold ideas into unforgettable reality, designing events that dare to defy the ordinary.

Pioneering Technology Incubator: ONAR Labs is a team of data scientists, engineers, and industry experts who are identifying, developing, and commercializing innovative marketing technology solutions born from servicing our agency clients, battle-tested by our network to ensure real-world applicability and impact.

ONAR’s network of agencies focuses on servicing companies ranging from $50M to $1B+ in revenue, and ONAR is actively searching for agencies to acquire and become part of the network.

NOTE TO INVESTORS: The latest news and updates relating to FAVO are available in the company’s newsroom at https://ibn.fm/ONAR

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

May 13, 2025 08:50:00

The opioid epidemic has prompted a re-evaluation of pain-management strategies, highlighting the importance of balancing effective treatment with abuse prevention
Nutriband’s AVERSA(TM) Fentanyl represents a significant advancement in this domain
The company’s strategic development of AVERSA Fentanyl follows a structured pharmaceutical lifecycle

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies this forward-thinking approach (https://ibn.fm/jhHMY).

The opioid epidemic has prompted a reevaluation of pain-management strategies, highlighting the importance of balancing effective treatment with abuse prevention. Traditional methods often involve limiting prescriptions, which can inadvertently hinder patients with…

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Secures Australian Approval to Launch Phase II Concussion Trial

May 13, 2025 08:45:00

Oragenics (NYSE American: OGEN) a biotechnology company developing intranasal therapies for brain-related disorders, announced it has received approval from Australia’s Human Research Ethics Committee (“HREC”) to begin a Phase II clinical trial of ONP-002, its proprietary neuroprotective therapy for mild traumatic brain injury (mTBI), or concussion. The clearance enables the company to initiate patient enrollment as early as Q2 2025 at Level 1 trauma emergency departments, where concussed patients are often treated. ONP-002, a non-invasive intranasal formulation, has demonstrated safety in Phase I and efficacy in preclinical models by reducing inflammation, oxidative stress and brain swelling. CEO Janet Huffman said the approval marks a key step toward expanding the ONP-002 program internationally, with enrollment sites also under consideration in New Zealand.

To view the full press release, visit https://ibn.fm/x4aaJ

About Oragenics

Oragenics is a development-stage biotechnology company focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (“mTBI”), also known as concussion, and for treating Niemann Pick Disease Type C (“NPC”), as well as proprietary powder formulation and an intranasal delivery device. For more information, visit the company’s website at www.Oragenics.com

NOTE TO INVESTORS: The latest news and updates relating to OGEN are available in the company’s newsroom at https://ibn.fm/OGEN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Prepares for Potential Fibromyalgia Drug Approval, Reports Q1 Results

May 13, 2025 08:43:03

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and reaffirmed its focus on the anticipated FDA decision for TNX-102 SL, a non-opioid analgesic for fibromyalgia, with a PDUFA goal date of Aug. 15. If approved, it would mark the first new drug class for fibromyalgia in more than 15 years. Tonix also highlighted progress across its pipeline, including positive Phase 1 data for TNX-1500 in kidney transplant rejection and strong preclinical results for TNX-801, a live-virus vaccine targeting mpox and smallpox. The company ended the quarter with $131.7 million in cash and cash equivalents and reported a net loss of $16.8 million on $2.4 million in product revenue.

To view the full press release, visit https://ibn.fm/X5U44

About Tonix Pharmaceuticals Holding Corp.

Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and modernizing solutions for public health challenges. Tonix’s priority is to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) this month for TNX-102 SL, a product candidate for which two statistically significant phase 3 studies have been completed for the management of fibromyalgia. TNX-102 SL was generally well tolerated in the phase 3 program. The FDA has granted Fast Track designation to TNX-102 SL for the management of fibromyalgia. TNX-102 SL is also being developed to treat acute stress reaction. Tonix recently announced that the U.S. Department of Defense (“DoD”), Defense Threat Reduction Agency (“DTRA”) awarded it a contract for up to $34 million over five years to develop TNX-4200, small molecule broad-spectrum antiviral agents targeting CD45 for the prevention or treatment of infections to improve the medical readiness of military personnel in biological threat environments. Tonix owns and operates a state-of-the art infectious disease research facility in Frederick, Maryland. The company’s Good Manufacturing Practice (“GMP”)-capable advanced manufacturing facility in Dartmouth, Maryland, was purpose-built to manufacture TNX-801, and the GMP suites are ready to be reactivated in case of a national or international emergency. Tonix’s development portfolio is focused on central nervous system (“CNS”) disorders. Tonix’s CNS portfolio includes TNX-1300 (cocaine esterase), a biologic in Phase 2 development designed to treat cocaine intoxication that has Breakthrough Therapy designation. Tonix’s immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease. Tonix Medicines, the company’s commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) 3 mg and Tosymra(R)(sumatriptan nasal spray) 10 mg for the treatment of acute migraine with or without aura in adults. For more information about the company, please visit www.TonixPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to TNXP are available in the company’s newsroom at https://ibn.fm/TNXP

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

RockBreaks – G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) to Restate 2024 Financials for Non-Cash Foreign Exchange Adjustments

May 13, 2025 08:35:16

G Mining Ventures Corp. (TSX: GMIN) (OTCQX: GMINF) announced plans to restate its 2024 consolidated financial statements and Management Discussion and Analysis due to two non-cash accounting adjustments totaling approximately $32 million related to IAS 21 foreign exchange treatment. The restatement, which has no impact on the company’s cash position, operations, or financial covenants, reclassifies $11 million in unrealized foreign exchange losses and $21 million in income tax recovery. Net income for Q4 2024 will be restated from $47.6 million to $15.2 million, and basic EPS from $0.21 to $0.07. Revised documents will be filed before the company releases Q1 2025 results on May 14, with a conference call scheduled for May 15.

To view the full press release, visit https://ibn.fm/GyGje

About G Mining Ventures Corp.

NOTE TO INVESTORS: The latest news and updates relating to GMINF are available in the company’s newsroom at https://ibn.fm/GMINF

About Rocks & Stocks

R&S is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Rocks & Stocks, text “Rocks” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://RocksAndStocks.news

Please see full terms of use and disclaimers on the Rocks & Stocks website applicable to all content provided by R&S, wherever published or re-published: https://RocksAndStocks.news/Disclaimer

Rocks & Stocks
Austin, Texas
RocksAndStocks.news
512.354.7000 Office
[email protected]

Rocks & Stocks is powered by IBN

BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins

May 13, 2025 08:35:00

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, reported a 20% sequential revenue increase to $728,867 in fiscal Q3 2025, driven by growth in cartridge sales, which now account for 58% of total revenue and strengthen its recurring revenue model. Gross profit surged 91% year-over-year to $341,368, while net loss narrowed by $434,141 to $2.54 million. INBS added 35 new accounts, bringing its active customer base to over 450, and continued expanding internationally through partnerships and multilingual system upgrades. The company also secured its sixth U.S. patent and advanced regulatory efforts across key global markets.

To view the full press release, visit https://ibn.fm/V56hu

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

NOTE TO INVESTORS: The latest news and updates relating to INBS are available in the company’s newsroom at https://ibn.fm/INBS

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications

May 13, 2025 08:25:00

CNS Pharmaceuticals (NASDAQ: CNSP) announced the successful transfer of Orphan Drug Designation from Cortice Biosciences for its lead asset TPI 287, covering gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. TPI 287, a microtubule-stabilizing abeotaxane, has shown potential to cross the blood-brain barrier and demonstrated encouraging results in a Phase 1 glioblastoma trial, including 3 complete and 9 partial responses among 23 evaluable patients. The company plans to initiate a Phase 2 study by year-end 2025 and highlighted the potential benefits of Orphan status, including seven years of market exclusivity upon approval.

To view the full press release, visit https://ibn.fm/7O5UX

About CNS Pharmaceuticals Inc.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Schedules May 14 Call to Present Q1 2025 Results and Corporate Update

May 13, 2025 08:15:00

SKYX Platforms (NASDAQ: SKYX), doing business as “SKYX Technologies,” announced it will host a corporate update call to review its first quarter 2025 financial results on Wednesday, May 14, at 4:30 p.m. ET. The call will feature Founder and Executive Chairman Rani Kohen, President Steve Schmidt (former CEO of Nielsen Data Corporation and President of Office Depot International), Co-CEO Lenny Sokolow, and CFO Marc Boisseau. The company is known for its disruptive advanced and smart home platform technologies and holds more than 97 issued and pending patents globally, along with a portfolio of over 60 lighting and home décor websites.

To view the full press release, visit https://ibn.fm/qojyo

About SKYX Platforms Corp.

NOTE TO INVESTORS: The latest news and updates relating to SKYX are available in the company’s newsroom at https://ibn.fm/SKYX

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Brera Holdings PLC (NASDAQ: BREA) Reiterates Commitment to the Successful MCO Model of Sustainable Football Investment; Continues to Grow International Media Visibility

May 13, 2025 08:05:00

Brera Holdings, an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs, has gained further recognition for the company’s commitment to its evolving model of sustainable football investment
A recent Wall Street Journal article focused on the dangers of trying to apply the American sports model to English soccer by acquiring trophy assets, a lesson that some U.S. owners have finally learned
Brera has successfully applied its multi-club ownership (“MCO”) approach, using its understanding and respect of English soccer’s advancement opportunities to grow and enrich its portfolio clubs, as shown with Brera’s acquisition agreement for S.S. Juve Stabia S.r.l. (“The Second Team of Naples”)
These initiatives point to the company’s commitment to growing its clubs and turning them into leading brands that can leave their mark on progressively higher sports stages

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, has emphasized its commitment to the evolving model of sustainable football investment, something it believes is integral to long-term value creation (https://ibn.fm/YaGK8).

A Wall Street Journal article, published on April 26, 2025, by Joshua Robinson, noted U.S.-led investments’ role in shaping football across the U.K. and Europe’s top-division clubs. Of note was Wrexham, owned by Hollywood stars Ryan Reynolds and Rob McElhenney. Wrexham was acquired as a…

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire Kadima Neuropsychiatry Institute

May 13, 2025 08:05:00

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a definitive agreement to acquire the Kadima Neuropsychiatry Institute. Kadima, a leading California clinic for interventional psychiatry, offers treatments such as ketamine, Spravato, transcranial magnetic stimulation (TMS), and medication management for CNS disorders including suicidal depression and PTSD. The clinic is profitable and expected to serve as the clinical model for future HOPE clinics. Dr. David Feifel, Kadima’s founder and a nationally recognized leader in interventional psychiatry, will join HOPE as its first Chief Medical Innovation Officer following the closing of the acquisition, which remains subject to customary conditions and financing.

To view the full press release, visit https://ibn.fm/T1WlB

About NRx Pharmaceuticals, Inc.

For more information, please visit https://www.nrxpharma.com/

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

Mazda Announces its EVs Will Use NACS Chargers in Japan

May 13, 2025 08:05:00

Mazda has officially announced that its future electric vehicles (EVs) in Japan will use the North American Charging Standard (NACS), which was developed by Tesla. Starting from 2027, new Mazda EVs sold in Japan will be built with NACS charging ports.

With more companies switching to the NACS system of chargers, it may become inevitable for others like Rivian Automotive Inc. (NASDAQ: RIVN) to follow suit to reap the benefits that come with using an…

About BillionDollarClub

BDC is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BillionDollarClub, text “Billion” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BillionDollarClub.com

BillionDollarClub
Los Angeles, CA
www.BillionDollarClub.com
310.299.1717 Office
[email protected]

BillionDollarClub is powered by IBN

Clean Energy Surges in the US, But Trump’s Policies Threaten Progress

May 13, 2025 08:05:00

A recent report has revealed that while renewable energy production in the U.S. has tripled in the past decade, its progress is being threatened by the Trump administration’s policies. Renewable energy projects in the U.S. are producing more clean energy than ever, but political uncertainty under President Donald Trump and billions of dollars in budget cuts could dampen America’s progress.

While the future outlook of U.S. clean energy may have dimmed somewhat, private sector players like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) have already made inroads into the market and the penetration of their products may still grow despite unfavorable policies at the…

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

Why the Crypto Bill in the US Senate Tanked

May 13, 2025 08:05:00

The crypto sector has just hit its first major obstacle under Donald Trump’s second term after enjoying a period of unprecedented support in Washington. Senate Democrats recently blocked a crypto measure that had strong backing from the industry, signaling a shift in momentum on Capitol Hill. While the proposal isn’t entirely off the table, its path forward is uncertain, especially as political divisions deepen.

Companies like Canaan Inc. (NASDAQ: CAN) will be watching to see how the lawmakers move to eventually pass the regulatory system that the industry has been…

About CryptoCurrencyWire

To receive SMS alerts from CryptoCurrencyWire, text “CRYPTO” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CryptoCurrencyWire.com

CryptoCurrencyWire
New York, NY
www.CryptoCurrencyWire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is powered by IBN

420 with CNW — Pennsylvania House Committee Passes Adult-Use Marijuana Bill

May 12, 2025 15:25:00

A measure now moving through Pennsylvania’s State House could make cannabis available in stores overseen by the state. On Monday, House Democrats narrowly approved the measure in the Health Committee with a 14-12 vote.

As the drug policy reform movement spreads across the remaining states that still had prohibitive policies in place, more companies like TerrAscend Corp. (TSND) (OTCQX: TSNDF) are likely to…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

CurrencyNewsBreaks – Aegis Capital Corp. Serves as Sole Book-Running Manager for Super League Enterprise (NASDAQ: SLE) $869,999 Public Offering

May 12, 2025 13:00:31

Aegis Capital is pleased to announce its role as the sole book-running manager in the recently completed underwritten public offering for Super League Enterprise, Inc. (NASDAQ: SLE). The offering comprised 5,117,647 shares of common stock at a public offering price of $0.17 per share, resulting in gross proceeds of approximately $869,999 before underwriting fees and expenses. The company also granted Aegis a 45-day overallotment option to purchase up to an additional 767,647 shares, which could increase total gross proceeds to $1 million if fully exercised.

Super League intends to use the net proceeds from the offering, combined with existing cash, for general corporate purposes, working capital, and repayment of a portion of its outstanding debt. Aegis is proud to support Super League in its mission to transform how brands connect with consumers through playable media.

To view the full press release, visit https://ibn.fm/9wFPo

About Aegis Capital Corporation 

Aegis Capital Corporation “Aegis” has been in business for over 40 years catering to the needs of private clients, institutions and corporations. Aegis was founded in 1984 and offers its investment representatives a conflict free service platform and can provide a full range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.  Aegis is able to provide quality service through its primary clearing relationship with RBC Clearing & Custody whose parent company, Royal Bank of Canada (NYSE: RY), is one of the world’s leading diversified financial services companies. Member: FINRA / SIPC.

For more information, visit the company’s website at: https://www.aegiscapcorp.com/

About CurrencyNewsWire

CurrencyNewsWire (“CNW”) is a state-of-the-art digital hub that aggregates and disseminates news and information covering the fast-moving financial markets. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. CNW covers companies, currencies and events that impact traditional fiat currencies and their market dynamics; cryptocurrencies, blockchain technologies and digital assets; the Federal Reserve’s policies and their influence on financial markets; global economic and monetary trends and their far-reaching influence; regulatory changes and their implication; as well as banking, finance, financial innovations, and investment strategies.

CNW is the central platform for understanding the multifaceted world of currencies and finance.

For more information, please visit https://www.CurrencyNewsWire.com

Please see full terms of use and disclaimers on the CurrencyNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CurrencyNewsWire.com/Disclaimer

CurrencyNewsWire
Austin, Texas
www.CurrencyNewsWire.com
512.354.7000 Office
[email protected]

CurrencyNewsWire is powered by IBN

CannabisNewsBreaks – CMB to Spotlight Future of Cannabis at NYC Expo

May 12, 2025 12:39:03

Cannabis Means Business (“CMB”), the industry’s premier business-to-business conference and expo, today shared new details on its schedule of panels and presentations, as well as programming, exhibitions and networking opportunities. The expo will feature a lineup of engaging speakers, including CNBC Fast Money trader Tim Seymour, Philip Wolf, a pioneer of the cannabis hospitality sector. and Dr. Chanda Macias, CEO of Women Grow.

“New York’s rapidly growing cannabis market, combined with its unmatched consumer base and global reach, creates a unique opportunity for businesses to thrive—and makes it the perfect backdrop for our event,” said CMB CEO and Founder Christine Ianuzzi. “Now, more than ever, it’s crucial to be in the right room, surrounded by innovators, investors, and decision-makers—this is where the future of cannabis commerce is taking shape.”

To view the full press release, visit https://cnw.fm/1XAWw

About Cannabis Means Business (“CMB”)

About CannabisNewsWire

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Austin, Texas
www.CannabisNewsWire.com
512.354.7000 Office
[email protected]

CannabisNewsWire is powered by IBN

InvestorNewsBreaks – IBN Tapped as Media Partner for DealFlow Discovery Day on Nuclear Energy

May 12, 2025 12:05:00

IBN (InvestorBrandNetwork), a multifaceted communications organization committed to connecting companies with the investment community through its dynamic portfolio of 60+ brands, today announced its engagement as the official media partner for DealFlow Events’ inaugural DealFlow Discovery Day on Nuclear Energy. The event is slated to take place on May 22, 2025, at the conveniently located Jay Suites in New York City.

“DealFlow produces industry-flagship events for investors and financial market participants. The upcoming conference will offer highly specialized educational and networking opportunities in the rapidly emerging nuclear energy space,” said IBN’s Director of Global Operations Randy Clark. “Our team is excited to be part of this new event series organized by DealFlow Events. We look forward to working closely with their team to drive maximum visibility among investor audiences.”

To view the full press release, visit https://ibn.fm/EPLFH

About IBN

IBN consists of financial brands introduced to the investment public over the course of 18+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (“DBP”), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Getting a Second Opinion After Breast Cancer Diagnosis Doesn’t Delay Treatment Commencement

May 12, 2025 09:05:00

It is very natural to feel immense anxiety and fear after receiving a breast cancer diagnosis. Most people don’t consider seeking second opinions and would rather begin treatment right away. After all, breast cancer is one of the deadliest types of cancer in women, second only to lung cancer in terms of fatalities. The Breast Cancer Research Foundation estimates that slightly over 42,000 women will die from the condition in 2025, making it one of the most prolific killers in the USA.

As more companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) invest in…

About TinyGems

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Los Angeles, CA
www.TinyGems.com
310.299.1717 Office

2024 Saw Almost 600 GW of Solar Installations Globally

May 12, 2025 09:05:00

The year 2024 was a big one for solar power. All around the world, countries worked hard to add new solar energy systems. By the end of the year, nearly 600 gigawatts (GW) of new solar power had been installed. This was a record-breaking number and showed how fast the world is turning to clean energy.

With more entities like SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) expanding their operations to…

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Los Angeles, CA
www.TechMediaWire.com
310.299.1717 Office
[email protected]

TechMediaWire is powered by IBN

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Announces $100 Million Project Financing from CIM Group for U.S. Solar Expansion

May 12, 2025 08:50:00

SolarBank and CIM Group have announced a US$100 million financing deal for a portfolio of U.S. solar energy projects totaling 97 MW.
The deal is structured as a preferred equity investment at the project level, preserving SolarBank’s share capital, with CIM receiving a 3% annual coupon and retaining full ownership of transferred investment tax credits.
SolarBank expects to maintain majority ownership of the 21-project portfolio post-financing, supporting SolarBank’s shift toward becoming a long-term solar asset owner in the U.S.

Disseminated on behalf of SolarBank Corporation

SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced a US$100 million project-based financing with infrastructure investor CIM Group to fund a 97 MW portfolio of solar energy projects in the United States. The deal marks a significant step in SolarBank’s evolution from solar developer to long-term asset owner, offering equity-style exposure to U.S. renewable energy growth without issuing new shares (https://ibn.fm/J7XIZ).

The financing will be structured as a preferred equity investment by CIM into a newly formed entity, New HoldCo. That entity will operate as a joint venture between CIM and Abundant Solar Power (“ASP”), a…

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the company’s newsroom at https://ibn.fm/SUUN

About GreenEnergyStocks

To receive SMS alerts from GreenEnergyStocks, text “Green” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenEnergyStocks.com

Please see full terms of use and disclaimers on the GreenEnergyStocks website applicable to all content provided by GES, wherever published or re-published: https://www.greennrgstocks.com/Disclaimer

GreenEnergyStocks
Los Angeles, CA
www.GreenEnergyStocks.com
310.299.1717 Office
[email protected]

GreenEnergyStocks is powered by IBN

TechMediaBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Hilton Garden Inn Near Disney’s Cotino Project

May 12, 2025 08:36:46

Nightfood Holdings (OTCQB: NGTF) announced the signing of a Letter of Intent to acquire the 120-room Hilton Garden Inn in Rancho Mirage, California for $36.93 million, marking one of the company’s largest deals to date. The hotel, adjacent to Disney’s Cotino(TM) residential resort community, will serve as a flagship site for Nightfood’s AI-powered Robotics-as-a-Service (“RaaS”) platform, which aims to reduce labor costs and enhance operational efficiency. The acquisition includes plans for a five-room expansion, a $3 million earn-out, and $26.43 million in Series C Preferred Stock, contingent on financial audits, mortgage conditions, and uplisting to a national exchange.

To view the full press release, visit https://ibn.fm/qTPzc

About Nightfood Holdings Inc.

Nightfood is a forward-thinking holding company dedicated to identifying and capitalizing on explosive market trends within the hospitality, food services, consumer packaged goods and commercial real estate sectors. The company’s mission is to create unparalleled upside potential in industries ripe for innovation and growth by leading newly emerging categories and seizing opportunities in markets undergoing transformational upheaval. Nightfood is at the forefront of introducing and deploying artificial intelligence-enabled robotics products, revolutionizing operational efficiencies and customer experiences across the company’s focus areas. Additionally, the company is committed to developing and marketing wellness-focused consumer packaged goods, meeting the growing demand for healthier and functional options. Through these strategic initiatives, Nightfood endeavors to drive significant value and growth for its stakeholders. For more information, visit the company’s website at www.NightFood.com.

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q1 2025 Results on May 15

May 12, 2025 08:25:15

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m. ET the same day to discuss the results and provide a corporate update.

To view the full press release, visit https://ibn.fm/f5iwL

About NRx Pharmaceuticals, Inc.

For more information, please visit  https://www.nrxpharma.com/

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

CryptoNewsBreaks – IBN Releases CryptoNewsAudio Interview Featuring Gordon Law Group on Crypto Tax Compliance

May 12, 2025 08:25:00

IBN, is pleased to announce the latest CryptoCurrencyWire audio production featuring Andrew Gordon, Managing Attorney of Gordon Law Group, a firm that focuses on helping individuals and businesses navigate the intricate world of digital asset taxation, including NFTs and DeFi. In the interview, Gordon outlines key steps for maintaining tax compliance in the crypto space, stressing that investors using multiple exchanges must take responsibility for gathering and organizing all relevant records. He notes that recordkeeping is a basic but crucial element of compliance, especially in a space where standardization across platforms is lacking.

Gordon also highlights the longstanding IRS requirement to report crypto as property, dating back to 2014, and the increasing visibility the agency now has into digital transactions. He explains how individuals can come into compliance by amending prior tax returns or using formal channels like the IRS Voluntary Disclosure Program. With the IRS now receiving data from a growing number of sources, including foreign exchanges, Gordon warns that enforcement efforts are ramping up—many taxpayers are already receiving warning letters. He encourages those affected to act proactively and seek professional guidance before more serious actions are taken.

To hear the full CryptoCurrencyWire audio production, visit https://ibn.fm/HJeUc

About IBN

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About CryptoCurrencyWire (“CCW”)

CryptoCurrencyWire (CCW) is a financial news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with CCW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, CCW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CCW brings its clients unparalleled visibility, recognition and brand awareness.

To receive instant SMS alerts, text CRYPTO to 888-902-4192 (U.S. Mobile Phones Only)

CryptoCurrency News Wire is where News, content and information converge via Crypto.

For more information, please visit https://www.cryptocurrencywire.com

Please see full terms of use and disclaimers on the CryptoCurrencyWire (CCW) website applicable to all content provided by CCW, wherever published or re-published: http://CCW.fm/Disclaimer

CryptoCurrencyWire (CCW)
New York, New York
www.cryptocurrencywire.com
212.994.9818 Office
[email protected]

CryptoCurrencyWire is part of the InvestorBrandNetwork.

RockBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Plans $1 Million Private Placement with Major Shareholder HCI

May 12, 2025 08:15:38

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced plans to raise approximately $1.01 million through a private placement of 800,000 common shares at $1.26 per share to major shareholder Hosken Consolidated Investments Limited (“HCI”), pending regulatory approval. The proceeds will support the company’s share of pre-construction activities at the Waterberg Project in South Africa and general corporate needs. The placement price reflects a 3.1% premium to the five-day VWAP on NYSE American as of May 9. Upon completion, HCI will return to a 26% ownership stake. The shares will be subject to a four-month-plus-one-day resale restriction and were offered under exemptions to registration and shareholder approval requirements due to HCI’s related-party status.

To view the full press release, visit https://ibn.fm/eYaW6

About Platinum Group Metals Ltd.

Platinum Group Metals is the operator of the Waterberg Project, a bulk underground palladium and platinum deposit located in South Africa. The Waterberg Project was discovered by Platinum Group and is being jointly developed with Implats, Mnombo and HJM. For more information about the company, visit www.PlatinumGroupMetals.net.

NOTE TO INVESTORS: The latest news and updates relating to PLG are available in the company’s newsroom at https://ibn.fm/PLG

About Rocks & Stocks

R&S is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Rocks & Stocks, text “Rocks” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://RocksAndStocks.news

Please see full terms of use and disclaimers on the Rocks & Stocks website applicable to all content provided by R&S, wherever published or re-published: https://RocksAndStocks.news/Disclaimer

Rocks & Stocks
Austin, Texas
RocksAndStocks.news
512.354.7000 Office
[email protected]

Rocks & Stocks is powered by IBN

InvestorNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Receives Noncompliance Notice from NYSE American Over Equity Threshold

May 12, 2025 08:15:00

NUBURU (NYSE American: BURU) has received a Notice of Noncompliance from NYSE Regulation for failing to meet the $2 million stockholders’ equity requirement under Section 1003(a)(i) of the NYSE American Company Guide, following continued operating losses and a going concern warning in its latest 10-K. The notice does not immediately impact BURU’s trading status, though its ticker now carries a “.BC” designation. The company has until May 29 to submit a plan to regain compliance and until Oct. 29, 2026 to meet the listing standards. Management cited recent strategic initiatives as potential paths to compliance, though their success is not guaranteed.

To view the full press release, visit https://ibn.fm/tGR3y

About NUBURU

NUBURU, Inc. was founded in 2015 as a developer and manufacturer of industrial blue laser technology that is transforming the speed and quality of laser-based manufacturing. Under its new management team led by Executive Chairman Alessandro Zamboni, NUBURU is executing a comprehensive growth and diversification strategy, expanding into complementary domains such as defense-tech, security, and operational resilience solutions. NUBURU is leveraging strategic partnerships and acquisitions to accelerate growth in high-value sectors.

For more information, visit www.nuburu.net .

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) to Host May 20 Webinar on Concussion Drug Program ONP-002

May 12, 2025 08:15:00

Oragenics (NYSE American: OGEN) will host a management update webinar on Tuesday, May 20, 2025, at 4:00 p.m. ET to discuss the unmet medical need in concussion treatment and highlight its lead candidate, ONP-002. The intranasal therapy is currently in a Phase IIa trial for mild traumatic brain injury and has shown promising preclinical results in reducing brain inflammation and swelling. Presenters will include CEO Janet Huffman, CMO Dr. James Kelly, and Chief Clinical Officer Dr. Frank Peacock, a national emergency medicine expert.

To view the full press release, visit https://ibn.fm/YOy9Q

About Oragenics

NOTE TO INVESTORS: The latest news and updates relating to OGEN are available in the company’s newsroom at https://ibn.fm/OGEN

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Wheaton Precious Metals Corp. (NYSE: WPM) (TSX: WPM) Reports Record Revenue and Raises Dividend in Strong Q1 2025

May 12, 2025 08:05:00

Wheaton Precious Metals (NYSE: WPM) (TSX: WPM) delivered record quarterly revenue of $470 million in Q1 2025, up 58.5% year over year, driven by a 36% increase in average realized gold equivalent prices and a 16% rise in GEOs sold. Adjusted net earnings rose 53% to $250.8 million, with operating cash flow climbing 64.5% to $361 million. The company declared a 6.5% dividend increase to $0.165 per share and highlighted its robust growth outlook, with four development projects expected to begin production in 2025. Wheaton ended the quarter with $1.1 billion in cash and no debt, supporting its ongoing expansion strategy and capital commitments.

To view the full press release, visit https://ibn.fm/HvWSy

About Wheaton Precious Metals Corp.

Wheaton Precious Metals is the world’s premier precious metals streaming company with the highest-quality portfolio of long-life, low-cost assets. Its business model offers investors leverage to commodity prices and exploration upside but with a much lower risk profile than a traditional mining company. Wheaton delivers amongst the highest cash operating margins in the mining industry, allowing it to pay a competitive dividend and continue to grow through accretive acquisitions.

NOTE TO INVESTORS: The latest news and updates relating to WPM are available in the company’s newsroom at https://ibn.fm/WPM

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Completes Dosing in Key Toxicity Studies for MS Drug Candidate

May 12, 2025 08:05:00

Quantum BioPharma (NASDAQ: QNTM) announced the completion of dosing in 90-day oral toxicity and toxicokinetic studies for its lead candidate Lucid-21-302 (“Lucid-MS”), a novel treatment in development for multiple sclerosis. The results of these studies will support an Investigational New Drug (IND) application to the U.S. FDA, expected by year-end. Executives highlighted the milestone as a major step toward launching a Phase 2 clinical trial and positioning Lucid-21-302 as a first-in-class therapy for MS.

To view the full press release, visit https://ibn.fm/euapt

About Quantum BioPharma Ltd.

Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“ Lucid ”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented UNBUZZD™ and spun out its OTC version to a company, Celly Nutrition Corp. (“ Celly Nutrition ”), led by industry veterans. Quantum BioPharma retains ownership of 25.71% (as of June 30, 2024) of Celly Nutrition at www.unbuzzd.com. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum BioPharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

NOTE TO INVESTORS: The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

Copper Supplies in China Expected to Fall Further, Increasing Supply Concerns

May 12, 2025 08:05:00

Copper inventories on the SHFE (Shanghai Futures Exchange) are forecast to further reduce at the end of this week. The quick drop in supplies is expected to trigger a rise in prices, which could incentivize traders to resume shipping the metal to China.

All in all, the supply-side concerns in China bode well for producers of copper, and companies like Torr Metals Inc. (TSX.V: TMET) could benefit from this tailwind as concerns grow about the future…

NOTE TO INVESTORS: The latest news and updates relating to Torr Metals Inc. (TSX.V: TMET) are available in the company’s newsroom at https://ibn.fm/TMET

About Rocks & Stocks

R&S is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from Rocks & Stocks, text “Rocks” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://RocksAndStocks.news

Please see full terms of use and disclaimers on the Rocks & Stocks website applicable to all content provided by R&S, wherever published or re-published: https://RocksAndStocks.news/Disclaimer

Rocks & Stocks
Los Angeles, CA
RocksAndStocks.news
310.299.1717 Office
[email protected]

Rocks & Stocks is powered by IBN

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Is ‘One to Watch’

May 12, 2025 08:05:00

Ucore currently owns an REE mining project and an advanced separation technology.
Commercial demonstration of the company’s RapidSX(TM) technology is at the commissioning stage.
Ucore plans several modern REE refineries in North America, with the first SMC slated to begin construction in Louisiana in 2023. This planned REE separation and rare earth oxide production plant is scheduled to process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.
Through its strategic partnerships with Kingston Process Metallurgy Inc., Mech-Chem Associates Inc. and other supporting contractors and vendors, Ucore is developing a North American REE supply chain.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX(TM), for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated…

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, CA
www.MiningNewsWire.com
310.299.1717 Office
[email protected]

MiningNewsWire is powered by IBN

420 with CNW — Study Finds Cannabis Dangerous to Developing Fetuses

May 9, 2025 15:25:00

New research shows that using cannabis while pregnant can put both the mother and baby at serious risk. A large-scale review of past studies found links between prenatal cannabis use and problems like low birth weight, premature birth, and even infant death.

As more jurisdictions enact marijuana policy changes, more research is likely to be conducted so that there is a better understanding of the specific ways in which cannabis products from companies like SNDL Inc. (NASDAQ: SNDL) positively or…

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]

CannabisNewsWire is powered by IBN

MiningNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Flagship Project Poised to Meet Surging Global PGM Needs

May 9, 2025 14:20:58

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is advancing the development of its Waterberg Project in South Africa, a large-scale platinum group metals (“PGM”) mine expected to be among the world’s largest and lowest-cost underground operations. In September 2024, an independent definitive feasibility study (“DFS”) was completed for Waterberg, highlighting its robust economics, including projected steady state annual production of 353,208 ounces of platinum, palladium, rhodium and gold, along with significant copper and nickel by-products, over a 54-year mine life. Located in the Bushveld Complex, the project features thick, shallow ore bodies allowing for safer, more efficient mining. Amid rising global demand for PGMs—especially in automotive, electronics, and clean energy sectors—Platinum Group Metals is strategically positioned to meet future market needs.

To view the full article, visit https://ibn.fm/IkAdQ

About Platinum Group Metals Ltd.

NOTE TO INVESTORS: The latest news and updates relating to PLG are available in the company’s newsroom athttps://ibn.fm/PLG

About MiningNewsWire

MNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from MiningNewsWire, text “BigHole” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Austin, Texas
www.MiningNewsWire.com
512.354.7000 Office
[email protected]

MiningNewsWire is powered by IBN

BioMedNewsBreaks — Calidi Biotherapeutics Inc. (NYSE American: CLDI) Eyes Game-Changing Approach to Cancer Treatment

May 9, 2025 13:57:22

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its innovative RTNova platform, which has successfully delivered transient gene-therapy payloads to targeted tumors. In addition, Calidi’s virotherapy demonstrated efficacy in killing more than 60 different tumor cell lines, showcasing the platform’s potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

“Targeting tumors with a systemic virotherapy with a multimodal mechanism of action, which includes direct killing of the tumors and robust activation of antitumor immune responses, may revolutionize the way we approach cancer treatments,” said a Calidi spokesman. “We are excited to have shown that our systemic platform can act also as a viral vector to express therapeutic genes in target tumors, which will maximize the potential of the designed treatment. With this breakthrough, we can use our platform to develop multiple assets for various indications, opening the door for potential partnership opportunities.”

To view the full article, visit https://ibn.fm/f3QE9

About Calidi Biotherapeutics Inc.

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, visit the company’s website at www.CalidiBio.com.

NOTE TO INVESTORS: The latest news and updates relating to CLDI are available in the company’s newsroom at https://ibn.fm/CLDI

About BioMedWire

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
[email protected]

BioMedWire is powered by IBN

InvestorNewsBreaks – Spotlight on Nuclear: DealFlow Discovery Day Set to Energize Investment

May 9, 2025 12:15:00

DealFlow Events today announced the launch of the inaugural DealFlow Discovery Day on Nuclear Energy, slated to take place in New York City on May 22, 2025. The event provides a forum for discovering new investment opportunities and exchanging ideas with industry stakeholders including utilities, financiers, site developers, technology providers, and government entities. Especially timely in light of the renaissance in the nuclear energy sector on the back of strong demand for clean energy and the intensive operations of data centers and AI technologies, the event will feature an insights-packed agenda. Thought leaders and top management of companies in the sector will share first-hand perspectives on a variety of pertinent industry topics, including business models, sectoral opportunities and challenges, and avenues of future expansion. The platform provides a unique opportunity for CEOs and senior leadership teams to showcase their companies to professional investors.

To view the full press release, visit https://ibn.fm/W6E2N

About DealFlow Events

DealFlow, the host of hundreds of events over the past 20 years, presents The Microcap Event. DealFlow is renowned for its SPAC, PIPE, Reg A, Activist Investor, Venture Debt, and other investment-themed events. For more information and a list of upcoming events, visit https://dealflowevents.com.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – NUBURU, Inc. (NYSE American: BURU) Launches Strategic Revamp of Blue-Laser Unit with Defense Focus

May 9, 2025 10:55:00

NUBURU (NYSE American: BURU) has announced the formation of a strategic working group to revitalize its Blue-Laser Business Unit, aiming to strengthen its position in the defense sector. The move follows a Joint-Pursuit Agreement with a defense-tech partner and plans to introduce vertical applications that enable cross-selling to existing and new clients. NUBURU is also advancing discussions to bring in a senior revenue and marketing strategist, while leveraging AI-driven insights from NexGenAI Solutions Group. The initiative includes the development of a new state-of-the-art operational facility to support this next phase of growth.

To view the full press release, visit https://ibn.fm/gD4Y1

About NUBURU

For more information, visit www.nuburu.net.

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

InvestorNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Joins AUVSI to Advance National Robotics Strategy and Policy

May 9, 2025 10:30:00

Knightscope (NASDAQ: KSCP) has joined the Association for Uncrewed Vehicle Systems International (“AUVSI”), reinforcing its commitment to autonomous security innovation and federal policy leadership. The company will participate in AUVSI’s Cyber, Ground, and Defense Advocacy Committees, including a new Robotics Subcommittee focused on shaping a National Robotics Strategy. Knightscope plans to contribute its expertise in autonomous ground robotics and AI-driven public safety systems to help guide U.S. standards and legislation for uncrewed technologies.

To view the full press release, visit https://ibn.fm/h7iOM

About Knightscope, Inc.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN

TechMediaBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Reports Record Revenue, Gross Profit and Cash Balance along with Quantum Supremacy Breakthrough in Q1

May 9, 2025 10:20:00

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, posted record first quarter 2025 revenue of $15 million, up 509% from the prior year. Business and financial results for the quarter included the first Advantage™ annealing quantum computer sale and publication of breakthrough research demonstrating quantum supremacy on a real-world problem.

The company ended the quarter with a record $304.3 million in cash on hand. Consolidated gross margin rose to 92.5%, with the company citing sufficient liquidity to reach profitability.

To view the full press release, visit https://ibn.fm/oSLnE

About D-Wave Quantum Inc.

D-Wave is a leader in the development and delivery of quantum computing systems, software, and services. We are the world’s first commercial supplier of quantum computers, and the only company building both annealing and gate-model quantum computers. Our mission is to help customers realize the value of quantum, today. Our 5,000+ qubit Advantage quantum computers, the world’s largest, are available on-premises or via the cloud, supported by 99.9% availability and uptime. More than 100 organizations trust D-Wave with their toughest computational challenges. With over 200 million problems submitted to our Advantage and Advantage2™ systems to date, our customers apply our technology to address use cases spanning optimization, artificial intelligence, research and more. Learn more about realizing the value of quantum computing today and how we’re shaping the quantum-driven industrial and societal advancements of tomorrow: www.dwavequantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

About TechMediaWire

To receive SMS alerts from TechMediaWire, text “TECH” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer

TechMediaWire
Austin, Texas
www.TechMediaWire.com
512.354.7000 Office
[email protected]

TechMediaWire is powered by IBN

Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells